BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1162161 Cc1cc(Nc2ncnc(NC(=O)C3CC3)n2)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C20H23N7O3/c1-11-9-13(23-18-21-10-22-19(25-18)24-15(28)12-5-6-12)17(30)27-14(11)16(29)26-20(27)7-3-2-4-8-20/h9-10,12H,2-8H2,1H3,(H,26,29)(H2,21,22,23,24,25,28) PEVWQIHBYGFSJE-UHFFFAOYSA-N 550483 N-{4-[(8′-Methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]-1,3,5-triazin-2-yl}cyclopropanecarboxamide::US11311520, Example 1 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 2.50 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550483&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259077 469794489 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162162 Cc1cc(Nc2ncnc(N)n2)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C16H19N7O2/c1-9-7-10(20-15-19-8-18-14(17)21-15)13(25)23-11(9)12(24)22-16(23)5-3-2-4-6-16/h7-8H,2-6H2,1H3,(H,22,24)(H3,17,18,19,20,21) RNSDILXFUJPTQP-UHFFFAOYSA-N 550508 6′-[(4-Amino-1,3,5-triazin-2-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 2 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 6.40 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550508 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550508&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259157 469794514 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162163 CCCNC(=O)Nc1ncnc(Nc2cc(C)c3C(=O)NC4(CCCCC4)n3c2=O)n1 InChI=1S/C20H26N8O3/c1-3-9-21-19(31)26-18-23-11-22-17(25-18)24-13-10-12(2)14-15(29)27-20(28(14)16(13)30)7-5-4-6-8-20/h10-11H,3-9H2,1-2H3,(H,27,29)(H3,21,22,23,24,25,26,31) MUJMCWILPCMQNC-UHFFFAOYSA-N 550509 1-{4-[(8′-Methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]-1,3,5-triazin-2-yl}-3-propylurea::US11311520, Example 3 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 18.8 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550509 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550509&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135258934 469794515 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162164 Cc1cc(Nc2ccnc3ccccc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C22H22N4O2/c1-14-13-18(24-17-9-12-23-16-8-4-3-7-15(16)17)21(28)26-19(14)20(27)25-22(26)10-5-2-6-11-22/h3-4,7-9,12-13H,2,5-6,10-11H2,1H3,(H,23,24)(H,25,27) ZWXYPUMKAQQDDR-UHFFFAOYSA-N 550510 8′-Methyl-6′-(quinolin-4-ylamino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 4 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 306 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550510 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550510&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402607 469794516 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162165 Cc1cc(Nc2ncnc3sccc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C19H19N5O2S/c1-11-9-13(22-15-12-5-8-27-17(12)21-10-20-15)18(26)24-14(11)16(25)23-19(24)6-3-2-4-7-19/h5,8-10H,2-4,6-7H2,1H3,(H,23,25)(H,20,21,22) KHEAAUBMEWQKAR-UHFFFAOYSA-N 550511 8′-Methyl-6′-(thieno[2,3-d]pyrimidin-4-ylamino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 31::US11311520, Example 5 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 6.40 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550511 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550511&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259073 469794517 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162166 Cc1cc(Nc2ncnc3[nH]ccc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C19H20N6O2/c1-11-9-13(23-16-12-5-8-20-15(12)21-10-22-16)18(27)25-14(11)17(26)24-19(25)6-3-2-4-7-19/h5,8-10H,2-4,6-7H2,1H3,(H,24,26)(H2,20,21,22,23) GGQRXDUQEQDVOP-UHFFFAOYSA-N 550512 8′-Methyl-6′-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 32::US11311520, Example 6 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 0.300 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550512 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550512&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135258971 469794518 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162167 Cc1cc(Nc2ncnc3[nH]ncc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C18H19N7O2/c1-10-7-12(22-14-11-8-21-24-15(11)20-9-19-14)17(27)25-13(10)16(26)23-18(25)5-3-2-4-6-18/h7-9H,2-6H2,1H3,(H,23,26)(H2,19,20,21,22,24) HUJYOLLPLFXSSL-UHFFFAOYSA-N 550513 8′-Methyl-6′-(1H-pyrazolo[3,4-d]pyrimidin-4-ylamino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 34::US11311520, Example 7 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 2.00 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550513&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259258 469794519 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162168 Cc1cc(Nc2ncnc3ccccc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C21H21N5O2/c1-13-11-16(24-18-14-7-3-4-8-15(14)22-12-23-18)20(28)26-17(13)19(27)25-21(26)9-5-2-6-10-21/h3-4,7-8,11-12H,2,5-6,9-10H2,1H3,(H,25,27)(H,22,23,24) KXNWBMFIJJTUAW-UHFFFAOYSA-N 550514 8′-Methyl-6′-(quinazolin-4-ylamino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 8 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 28.3 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550514 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550514&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402583 469794520 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162169 Cc1cc(Nc2ncnc3sc(cc23)C(O)=O)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C20H19N5O4S/c1-10-7-12(23-15-11-8-13(19(28)29)30-17(11)22-9-21-15)18(27)25-14(10)16(26)24-20(25)5-3-2-4-6-20/h7-9H,2-6H2,1H3,(H,24,26)(H,28,29)(H,21,22,23) KZYCRFUGUCTUIM-UHFFFAOYSA-N 550515 4-[(8′-Methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxylic acid::US11311520, Example 9 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 82.6 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550515 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550515&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240041 469794521 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162170 CN(C)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)ncnc2s1 InChI=1S/C22H24N6O3S/c1-12-9-14(20(30)28-16(12)18(29)26-22(28)7-5-4-6-8-22)25-17-13-10-15(21(31)27(2)3)32-19(13)24-11-23-17/h9-11H,4-8H2,1-3H3,(H,26,29)(H,23,24,25) CVNKHKZXCJJUFC-UHFFFAOYSA-N 550516 N,N-Dimethyl-4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 10::US11311520, Example 33 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 17.1 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550516 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550516&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259287 469794522 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162171 COCCN(C)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)ncnc2s1 InChI=1S/C24H28N6O4S/c1-14-11-16(22(32)30-18(14)20(31)28-24(30)7-5-4-6-8-24)27-19-15-12-17(35-21(15)26-13-25-19)23(33)29(2)9-10-34-3/h11-13H,4-10H2,1-3H3,(H,28,31)(H,25,26,27) BDNOUMSCVFVQMZ-UHFFFAOYSA-N 550517 N-(2-Methoxyethy)-N-methyl-4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 11 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 36.9 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550517&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259100 469794523 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162172 CN1CCN(CC1)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)ncnc2s1 InChI=1S/C25H29N7O3S/c1-15-12-17(23(34)32-19(15)21(33)29-25(32)6-4-3-5-7-25)28-20-16-13-18(36-22(16)27-14-26-20)24(35)31-10-8-30(2)9-11-31/h12-14H,3-11H2,1-2H3,(H,29,33)(H,26,27,28) SMMHOYZAUWAWHV-UHFFFAOYSA-N 550518 8′-Methyl-6′-({6-[(4-methylpiperazin-1-yl)carbonyl]thieno[2,3-d]pyrimidin-4-yl}amino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 12 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 27.2 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550518 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550518&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259088 469794524 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162173 CN(C)CCN(C)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)ncnc2s1 InChI=1S/C25H31N7O3S/c1-15-12-17(23(34)32-19(15)21(33)29-25(32)8-6-5-7-9-25)28-20-16-13-18(36-22(16)27-14-26-20)24(35)31(4)11-10-30(2)3/h12-14H,5-11H2,1-4H3,(H,29,33)(H,26,27,28) XFTOCQRBWVQUGG-UHFFFAOYSA-N 550519 N-[2-(Dimethylamino)ethyl]-N-methyl-4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 13 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.20 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550519 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550519&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259195 469794525 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162174 CN(C)C1CCN(CC1)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)ncnc2s1 InChI=1S/C27H33N7O3S/c1-16-13-19(25(36)34-21(16)23(35)31-27(34)9-5-4-6-10-27)30-22-18-14-20(38-24(18)29-15-28-22)26(37)33-11-7-17(8-12-33)32(2)3/h13-15,17H,4-12H2,1-3H3,(H,31,35)(H,28,29,30) MHOOTEBCVWZSJN-UHFFFAOYSA-N 550520 6′-[(6-{[4-(Dimethylamino)piperidin-1-yl]carbonyl}thieno[2,3-d]pyrimidin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 14 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 4.10 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550520 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550520&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402584 469794526 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162175 Cc1c(sc2ncnc(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)c12)C(O)=O InChI=1S/C21H21N5O4S/c1-10-8-12(19(28)26-14(10)17(27)25-21(26)6-4-3-5-7-21)24-16-13-11(2)15(20(29)30)31-18(13)23-9-22-16/h8-9H,3-7H2,1-2H3,(H,25,27)(H,29,30)(H,22,23,24) VQBBDBIJZMIGRN-UHFFFAOYSA-N 550521 5-Methyl-4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxylic acid::US11311520, Example 15 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 21.3 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550521 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550521&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259074 469794527 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162176 CN(C)C(=O)c1sc2ncnc(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)c2c1C InChI=1S/C23H26N6O3S/c1-12-10-14(21(31)29-16(12)19(30)27-23(29)8-6-5-7-9-23)26-18-15-13(2)17(22(32)28(3)4)33-20(15)25-11-24-18/h10-11H,5-9H2,1-4H3,(H,27,30)(H,24,25,26) DAFZLXYSHUYACA-UHFFFAOYSA-N 550522 N,N,5-trimethyl-4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 16 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 66.7 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550522 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550522&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402569 469794528 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162177 CN(C)CCN(C)C(=O)c1sc2ncnc(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)c2c1C InChI=1S/C26H33N7O3S/c1-15-13-17(24(35)33-19(15)22(34)30-26(33)9-7-6-8-10-26)29-21-18-16(2)20(37-23(18)28-14-27-21)25(36)32(5)12-11-31(3)4/h13-14H,6-12H2,1-5H3,(H,30,34)(H,27,28,29) FCLMLHOXVRPCME-UHFFFAOYSA-N 550523 N-[2-(dimethylamino)ethyl]-N,5-dimethyl-4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 17 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 40.3 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550523 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550523&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259214 469794529 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162178 COCCN(C)C(=O)c1sc2ncnc(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)c2c1C InChI=1S/C25H30N6O4S/c1-14-12-16(23(33)31-18(14)21(32)29-25(31)8-6-5-7-9-25)28-20-17-15(2)19(36-22(17)27-13-26-20)24(34)30(3)10-11-35-4/h12-13H,5-11H2,1-4H3,(H,29,32)(H,26,27,28) DZYGJOONYDVWKY-UHFFFAOYSA-N 550524 N-(2-methoxyethyl)-N,5-dimethyl-4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 18 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 105 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550524 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550524&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259198 469794530 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162179 CN1CCN(CC1)C(=O)c1sc2ncnc(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)c2c1C InChI=1S/C26H31N7O3S/c1-15-13-17(24(35)33-19(15)22(34)30-26(33)7-5-4-6-8-26)29-21-18-16(2)20(37-23(18)28-14-27-21)25(36)32-11-9-31(3)10-12-32/h13-14H,4-12H2,1-3H3,(H,30,34)(H,27,28,29) UTTNMHMFNXWHMO-UHFFFAOYSA-N 550525 8′-methyl-6′-({5-methyl-6-[(4-methylpiperazin-1-yl)carbonyl]thieno[2,3-d]pyrimidin-4-yl}amino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 19 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 34.2 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550525 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550525&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259208 469794531 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162180 CN(C)C1CCN(CC1)C(=O)c1sc2ncnc(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)c2c1C InChI=1S/C28H35N7O3S/c1-16-14-19(26(37)35-21(16)24(36)32-28(35)10-6-5-7-11-28)31-23-20-17(2)22(39-25(20)30-15-29-23)27(38)34-12-8-18(9-13-34)33(3)4/h14-15,18H,5-13H2,1-4H3,(H,32,36)(H,29,30,31) JKUWQVUUIFDSMW-UHFFFAOYSA-N 550526 6′-[(6-{[4-(Dimethylamino)piperidin-1-yl]carbonyl}-5-methylthieno[2,3-d]pyrimidin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 20 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 35.2 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550526 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550526&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146257738 469794532 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162181 Cc1cc(Nc2ccnc(N)n2)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C17H20N6O2/c1-10-9-11(20-12-5-8-19-16(18)21-12)15(25)23-13(10)14(24)22-17(23)6-3-2-4-7-17/h5,8-9H,2-4,6-7H2,1H3,(H,22,24)(H3,18,19,20,21) ZBOZMNJGIZGSFL-UHFFFAOYSA-N 50545853 CHEMBL4784364::US11311520, Example 21 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 339 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50545853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50545853&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402620 461689616 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162182 Cc1cc(Nc2ccnc3[nH]ccc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C20H21N5O2/c1-12-11-15(23-14-6-10-22-17-13(14)5-9-21-17)19(27)25-16(12)18(26)24-20(25)7-3-2-4-8-20/h5-6,9-11H,2-4,7-8H2,1H3,(H,24,26)(H2,21,22,23) NVNRCGWASPBXBH-UHFFFAOYSA-N 550528 8′-Methyl-6′-(1H-pyrrolo[2,3-b]pyridin-4-ylamino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 22 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 12.3 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550528 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550528&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135258955 469794534 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162183 CCCNC(=O)Nc1nccc(Nc2cc(C)c3C(=O)NC4(CCCCC4)n3c2=O)n1 InChI=1S/C21H27N7O3/c1-3-10-23-20(31)26-19-22-11-7-15(25-19)24-14-12-13(2)16-17(29)27-21(28(16)18(14)30)8-5-4-6-9-21/h7,11-12H,3-6,8-10H2,1-2H3,(H,27,29)(H3,22,23,24,25,26,31) AEKVKLYUXPQRDB-UHFFFAOYSA-N 550529 1-{4-[(8′-Methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]pyrimidin-2-yl}-3-propylurea::US11311520, Example 23 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 337 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550529&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135258974 469794535 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162184 Cc1cc(Nc2ncnc3[nH]cnc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C18H19N7O2/c1-10-7-11(23-15-12-14(20-8-19-12)21-9-22-15)17(27)25-13(10)16(26)24-18(25)5-3-2-4-6-18/h7-9H,2-6H2,1H3,(H,24,26)(H2,19,20,21,22,23) KECQVLZLLUBJNX-UHFFFAOYSA-N 550530 8′-methyl-6′-(9H-purin-6-ylamino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 24 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 1.50 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550530 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550530&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259270 469794536 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162185 CN(C)CCNC(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)ncnc2s1 InChI=1S/C24H29N7O3S/c1-14-11-16(23(34)31-18(14)21(33)29-24(31)7-5-4-6-8-24)28-19-15-12-17(35-22(15)27-13-26-19)20(32)25-9-10-30(2)3/h11-13H,4-10H2,1-3H3,(H,25,32)(H,29,33)(H,26,27,28) LWTXLTOGFXEWSP-UHFFFAOYSA-N 550531 N-[2-(Dimethylamino)ethyl]-4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 25 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 1.90 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550531 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550531&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259135 469794537 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162186 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2CC(C2)C#N)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C24H23N7O3S/c1-13-7-16(22(33)31-18(13)20(32)29-24(31)5-3-2-4-6-24)28-19-15-8-17(35-21(15)27-12-26-19)23(34)30-10-14(9-25)11-30/h7-8,12,14H,2-6,10-11H2,1H3,(H,29,32)(H,26,27,28) GXRTUTYGJYEEKW-UHFFFAOYSA-N 550532 1-({4-[(8′-Methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidin-6-yl}carbonyl)azetidine-3-carbonitrile::US11311520, Example 26 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.00 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550532 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550532&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146257754 469794538 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162187 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2CC(C2)NC(=O)OC(C)(C)C)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C28H33N7O5S/c1-15-10-18(24(37)35-20(15)22(36)33-28(35)8-6-5-7-9-28)32-21-17-11-19(41-23(17)30-14-29-21)25(38)34-12-16(13-34)31-26(39)40-27(2,3)4/h10-11,14,16H,5-9,12-13H2,1-4H3,(H,31,39)(H,33,36)(H,29,30,32) BHDIJUOTDNAIJI-UHFFFAOYSA-N 550533 US11311520, Example 27::tert-Butyl [1-({4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidin-6-yl}carbonyl)azetidin-3-yl]carbamate MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 4.00 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550533 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550533&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402590 469794539 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162188 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2CC(N)C2)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C23H25N7O3S/c1-12-7-15(21(32)30-17(12)19(31)28-23(30)5-3-2-4-6-23)27-18-14-8-16(34-20(14)26-11-25-18)22(33)29-9-13(24)10-29/h7-8,11,13H,2-6,9-10,24H2,1H3,(H,28,31)(H,25,26,27) XFEFHVZCXJMXGZ-UHFFFAOYSA-N 550534 6′-({6-[(3-Aminoazetidin-1-yl)carbonyl]thieno[2,3-d]pyrimidin-4-yl}amino)-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 28 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 0.600 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550534 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550534&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259176 469794540 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162189 CN(C)[C@@H]1CCN(C1)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)ncnc2s1 InChI=1S/C26H31N7O3S/c1-15-11-18(24(35)33-20(15)22(34)30-26(33)8-5-4-6-9-26)29-21-17-12-19(37-23(17)28-14-27-21)25(36)32-10-7-16(13-32)31(2)3/h11-12,14,16H,4-10,13H2,1-3H3,(H,30,34)(H,27,28,29)/t16-/m1/s1 MLIDBVPZIJOWMP-MRXNPFEDSA-N 550535 6′-[(6-{[(3R)-3-(Dimethylamino)pyrrolidin-1-yl]carbonyl}thieno[2,3-d]pyrimidin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 29 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 2.90 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550535 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550535&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402630 469794541 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162190 CN(C)[C@H]1CCN(C1)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)ncnc2s1 InChI=1S/C26H31N7O3S/c1-15-11-18(24(35)33-20(15)22(34)30-26(33)8-5-4-6-9-26)29-21-17-12-19(37-23(17)28-14-27-21)25(36)32-10-7-16(13-32)31(2)3/h11-12,14,16H,4-10,13H2,1-3H3,(H,30,34)(H,27,28,29)/t16-/m0/s1 MLIDBVPZIJOWMP-INIZCTEOSA-N 550536 6′-[(6-{[(3S)-3-(Dimethylamino)pyrrolidin-1-yl]carbonyl}thieno[2,3-d]pyrimidin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 30 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 3.20 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550536 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550536&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402561 469794542 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162191 Cc1cc(Nc2ncnc3sccc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C19H19N5O2S/c1-11-9-13(22-15-12-5-8-27-17(12)21-10-20-15)18(26)24-14(11)16(25)23-19(24)6-3-2-4-7-19/h5,8-10H,2-4,6-7H2,1H3,(H,23,25)(H,20,21,22) KHEAAUBMEWQKAR-UHFFFAOYSA-N 550511 8′-Methyl-6′-(thieno[2,3-d]pyrimidin-4-ylamino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 31::US11311520, Example 5 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 16.8 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550511 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550511&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259073 469794517 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162192 Cc1cc(Nc2ncnc3[nH]ccc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C19H20N6O2/c1-11-9-13(23-16-12-5-8-20-15(12)21-10-22-16)18(27)25-14(11)17(26)24-19(25)6-3-2-4-7-19/h5,8-10H,2-4,6-7H2,1H3,(H,24,26)(H2,20,21,22,23) GGQRXDUQEQDVOP-UHFFFAOYSA-N 550512 8′-Methyl-6′-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 32::US11311520, Example 6 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 0.300 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550512 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550512&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135258971 469794518 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162193 CN(C)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)ncnc2s1 InChI=1S/C22H24N6O3S/c1-12-9-14(20(30)28-16(12)18(29)26-22(28)7-5-4-6-8-22)25-17-13-10-15(21(31)27(2)3)32-19(13)24-11-23-17/h9-11H,4-8H2,1-3H3,(H,26,29)(H,23,24,25) CVNKHKZXCJJUFC-UHFFFAOYSA-N 550516 N,N-Dimethyl-4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 10::US11311520, Example 33 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 70.7 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550516 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550516&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259287 469794522 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162194 Cc1cc(Nc2ncnc3[nH]ncc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C18H19N7O2/c1-10-7-12(22-14-11-8-21-24-15(11)20-9-19-14)17(27)25-13(10)16(26)23-18(25)5-3-2-4-6-18/h7-9H,2-6H2,1H3,(H,23,26)(H2,19,20,21,22,24) HUJYOLLPLFXSSL-UHFFFAOYSA-N 550513 8′-Methyl-6′-(1H-pyrazolo[3,4-d]pyrimidin-4-ylamino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 34::US11311520, Example 7 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 8.10 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550513&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259258 469794519 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162195 Cc1cc(Nc2ncnc3CN(Cc23)C(=O)OC(C)(C)C)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C24H30N6O4/c1-14-10-16(21(32)30-18(14)20(31)28-24(30)8-6-5-7-9-24)27-19-15-11-29(12-17(15)25-13-26-19)22(33)34-23(2,3)4/h10,13H,5-9,11-12H2,1-4H3,(H,28,31)(H,25,26,27) OADKAEOGMCWFFX-UHFFFAOYSA-N 550541 US11311520, Example 35::tert-Butyl 4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxylate MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 4.10 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550541 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550541&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259114 469794543 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162196 Cc1cc(Nc2ncnc3CNCc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C19H22N6O2/c1-11-7-13(23-16-12-8-20-9-14(12)21-10-22-16)18(27)25-15(11)17(26)24-19(25)5-3-2-4-6-19/h7,10,20H,2-6,8-9H2,1H3,(H,24,26)(H,21,22,23) JYCXFYJOYFEGPD-UHFFFAOYSA-N 550542 6′-(6,7-Dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-ylamino)-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 36 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 19.1 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550542 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550542&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402541 469794544 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162197 Cc1cc(Nc2ncnc3nc(CC(F)(F)F)[nH]c23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C20H20F3N7O2/c1-10-7-11(18(32)30-14(10)17(31)29-19(30)5-3-2-4-6-19)26-15-13-16(25-9-24-15)28-12(27-13)8-20(21,22)23/h7,9H,2-6,8H2,1H3,(H,29,31)(H2,24,25,26,27,28) BLQKJMZDFIHVNS-UHFFFAOYSA-N 550543 8′-Methyl-6′-{[8-(2,2,2-trifluoroethyl)-7H-purin-6-yl]amino}-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 37 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 10.3 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550543 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550543&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402579 469794545 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162198 Cc1oc2ncnc(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)c2c1C InChI=1S/C21H23N5O3/c1-11-9-14(24-17-15-12(2)13(3)29-19(15)23-10-22-17)20(28)26-16(11)18(27)25-21(26)7-5-4-6-8-21/h9-10H,4-8H2,1-3H3,(H,25,27)(H,22,23,24) FKWOFVRFEGWALA-UHFFFAOYSA-N 550544 6′-[(5,6-Dimethylfuro[2,3-d]pyrimidin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 38 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 79.9 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550544 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550544&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259085 469794546 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162199 CC(O)Cn1cnc2c(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)ncnc12 InChI=1S/C21H25N7O3/c1-12-8-14(20(31)28-16(12)19(30)26-21(28)6-4-3-5-7-21)25-17-15-18(23-10-22-17)27(11-24-15)9-13(2)29/h8,10-11,13,29H,3-7,9H2,1-2H3,(H,26,30)(H,22,23,25) PWHREABFBGRUFP-UHFFFAOYSA-N 550545 (RS)-6′-{[9-(2-Hydroxypropyl)-9H-purin-6-yl]amino}-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 39 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 744 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550545 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550545&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259209 469794547 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162200 Cc1cc(Nc2ncnc(NC(=O)C3CC3)n2)c(=O)n2c1C(=O)NC2(C)C InChI=1S/C17H19N7O3/c1-8-6-10(14(27)24-11(8)13(26)23-17(24,2)3)20-15-18-7-19-16(22-15)21-12(25)9-4-5-9/h6-7,9H,4-5H2,1-3H3,(H,23,26)(H2,18,19,20,21,22,25) FSBMJORUZDXYLW-UHFFFAOYSA-N 550546 N-[4-[(3,3,8-Trimethyl-1,5-dioxo-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino]-1,3,5-triazin-2-yl]cyclopropanecarboxamide::US11311520, Example 40 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 20.7 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550546 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550546&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240045 469794548 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162201 Cc1cc(Nc2ncnc3cccc(F)c23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C21H20FN5O2/c1-12-10-15(25-18-16-13(22)6-5-7-14(16)23-11-24-18)20(29)27-17(12)19(28)26-21(27)8-3-2-4-9-21/h5-7,10-11H,2-4,8-9H2,1H3,(H,26,28)(H,23,24,25) VOXOQMUBGBQWNT-UHFFFAOYSA-N 550547 6′-[(5-Fluoroquinazolin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 41 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 14.0 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550547 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550547&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402602 469794549 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162202 CN1C[C@H]2C[C@@H]1CN2C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)ncnc2s1 InChI=1S/C26H29N7O3S/c1-14-8-18(24(35)33-20(14)22(34)30-26(33)6-4-3-5-7-26)29-21-17-10-19(37-23(17)28-13-27-21)25(36)32-12-15-9-16(32)11-31(15)2/h8,10,13,15-16H,3-7,9,11-12H2,1-2H3,(H,30,34)(H,27,28,29)/t15-,16-/m1/s1 DNCHAKVJQAAYPL-HZPDHXFCSA-N 550548 8′-Methyl-6′-[(6-{[(1R,4R)-5-methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]carbonyl}thieno[2,3-d]pyrimidin-4-yl)amino]-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 42 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 1.90 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550548 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550548&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402635 469794550 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162203 CN1C[C@@H]2C[C@H]1CN2C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)ncnc2s1 InChI=1S/C26H29N7O3S/c1-14-8-18(24(35)33-20(14)22(34)30-26(33)6-4-3-5-7-26)29-21-17-10-19(37-23(17)28-13-27-21)25(36)32-12-15-9-16(32)11-31(15)2/h8,10,13,15-16H,3-7,9,11-12H2,1-2H3,(H,30,34)(H,27,28,29)/t15-,16-/m0/s1 DNCHAKVJQAAYPL-HOTGVXAUSA-N 550549 8′-Methyl-6′-[(6-{[(1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]carbonyl}thieno[2,3-d]pyrimidin-4-yl)amino]-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 43 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 2.90 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550549 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550549&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402551 469794551 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162204 Cc1cc(Nc2ncnc3n(CCO)cnc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C20H23N7O3/c1-12-9-13(24-16-14-17(22-10-21-16)26(7-8-28)11-23-14)19(30)27-15(12)18(29)25-20(27)5-3-2-4-6-20/h9-11,28H,2-8H2,1H3,(H,25,29)(H,21,22,24) IFBLKCIOKKNRFJ-UHFFFAOYSA-N 550550 6′-{[9-(2-Hydroxyethyl)-9H-purin-6-yl]amino}-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 44 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 465 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550550&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259091 469794552 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162205 CCOC(=O)Cn1cnc2c(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)ncnc12 InChI=1S/C22H25N7O4/c1-3-33-15(30)10-28-12-25-16-18(23-11-24-19(16)28)26-14-9-13(2)17-20(31)27-22(29(17)21(14)32)7-5-4-6-8-22/h9,11-12H,3-8,10H2,1-2H3,(H,27,31)(H,23,24,26) VFBFQGGOHAFSAJ-UHFFFAOYSA-N 550551 Ethyl {6-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]-9H-purin-9-yl}acetate::US11311520, Example 45 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 603 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550551 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550551&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259297 469794553 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162206 Cc1cc(Nc2ncnc3ccc(Cl)cc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C21H20ClN5O2/c1-12-9-16(25-18-14-10-13(22)5-6-15(14)23-11-24-18)20(29)27-17(12)19(28)26-21(27)7-3-2-4-8-21/h5-6,9-11H,2-4,7-8H2,1H3,(H,26,28)(H,23,24,25) BVRUWLWYDBHGJR-UHFFFAOYSA-N 550552 6′-[(6-Chloroquinazolin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 46 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 4.10 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550552 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550552&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402616 469794554 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162207 Cc1cc(Nc2ncnc3n(cnc23)[C@H]2O[C@@H](CO)[C@H](O)[C@H]2O)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C23H27N7O6/c1-11-7-12(21(35)30-15(11)20(34)28-23(30)5-3-2-4-6-23)27-18-14-19(25-9-24-18)29(10-26-14)22-17(33)16(32)13(8-31)36-22/h7,9-10,13,16-17,22,31-33H,2-6,8H2,1H3,(H,28,34)(H,24,25,27)/t13-,16-,17+,22-/m0/s1 CWBONJWRTXSILL-PLKWALTGSA-N 550553 N-[9-(beta-L-Arabinofuranosyl)-9H-purin-6-yl]-8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-amine::US11311520, Example 47 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 47.2 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550553 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550553&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259097 469794555 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162208 Cc1cc(Nc2ncnc3n(CC(O)=O)cnc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C20H21N7O4/c1-11-7-12(19(31)27-15(11)18(30)25-20(27)5-3-2-4-6-20)24-16-14-17(22-9-21-16)26(10-23-14)8-13(28)29/h7,9-10H,2-6,8H2,1H3,(H,25,30)(H,28,29)(H,21,22,24) IYAMRTOPVJIACI-UHFFFAOYSA-N 550554 US11311520, Example 48::{6-[(8′-Methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]-9H-purin-9-yl}acetic acid MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 29.4 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550554 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550554&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259067 469794556 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162209 CN(C)C(=O)Cn1cnc2c(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)ncnc12 InChI=1S/C22H26N8O3/c1-13-9-14(21(33)30-17(13)20(32)27-22(30)7-5-4-6-8-22)26-18-16-19(24-11-23-18)29(12-25-16)10-15(31)28(2)3/h9,11-12H,4-8,10H2,1-3H3,(H,27,32)(H,23,24,26) BIBKPLJGIGAVPZ-UHFFFAOYSA-N 550555 N,N-Dimethyl-2-{6-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]-9H-purin-9-yl}acetamide::US11311520, Example 49 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 490 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550555&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259164 469794557 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162210 CN(C)CCN(C)C(=O)Cn1cnc2c(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)ncnc12 InChI=1S/C25H33N9O3/c1-16-12-17(24(37)34-20(16)23(36)30-25(34)8-6-5-7-9-25)29-21-19-22(27-14-26-21)33(15-28-19)13-18(35)32(4)11-10-31(2)3/h12,14-15H,5-11,13H2,1-4H3,(H,30,36)(H,26,27,29) LLVYMADEMYRZBZ-UHFFFAOYSA-N 550556 N-[2-(Dimethylamino)ethyl]-N-methyl-2-{6-[(8′-methyl-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]-9H-purin-9-yl}acetamide::US11311520, Example 50 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 950 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550556 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550556&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259205 469794558 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162211 Cc1cc(Nc2ncnc3scnc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C18H18N6O2S/c1-10-7-11(22-14-12-16(20-8-19-14)27-9-21-12)17(26)24-13(10)15(25)23-18(24)5-3-2-4-6-18/h7-9H,2-6H2,1H3,(H,23,25)(H,19,20,22) GJPHJIZWWZIFLM-UHFFFAOYSA-N 550557 8′-Methyl-6′-([1,3]thiazolo[5,4-d]pyrimidin-7-ylamino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 51 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 2.90 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550557 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550557&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259296 469794559 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162212 Cc1cc(Nc2ncnc3occc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C19H19N5O3/c1-11-9-13(22-15-12-5-8-27-17(12)21-10-20-15)18(26)24-14(11)16(25)23-19(24)6-3-2-4-7-19/h5,8-10H,2-4,6-7H2,1H3,(H,23,25)(H,20,21,22) UJRPXOAIHVVDPR-UHFFFAOYSA-N 550558 6′-(Furo[2,3-d]pyrimidin-4-ylamino)-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 52 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 13.0 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550558 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550558&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259076 469794560 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162213 Cc1cc(Nc2ncnc(NC(=O)C3CC3)n2)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C19H21N7O3/c1-10-8-12(16(29)26-13(10)15(28)25-19(26)6-2-3-7-19)22-17-20-9-21-18(24-17)23-14(27)11-4-5-11/h8-9,11H,2-7H2,1H3,(H,25,28)(H2,20,21,22,23,24,27) UMJXVDYBDMDKBY-UHFFFAOYSA-N 550559 N-{4-[(8′-Methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]-1,3,5-triazin-2-yl}cyclopropanecarboxamide::US11311520, Example 53 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 2.40 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550559&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402605 469794561 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162214 Cc1cc(Nc2ncnc(N)n2)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C15H17N7O2/c1-8-6-9(19-14-18-7-17-13(16)20-14)12(24)22-10(8)11(23)21-15(22)4-2-3-5-15/h6-7H,2-5H2,1H3,(H,21,23)(H3,16,17,18,19,20) ZEUANWCMVGRFIY-UHFFFAOYSA-N 550560 6′-[(4-Amino-1,3,5-triazin-2-yl)amino]-8′-methyl-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 54 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.70 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550560 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550560&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402628 469794562 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162215 Cc1cc(Nc2ncnc3[nH]ccc23)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C18H18N6O2/c1-10-8-12(22-15-11-4-7-19-14(11)20-9-21-15)17(26)24-13(10)16(25)23-18(24)5-2-3-6-18/h4,7-9H,2-3,5-6H2,1H3,(H,23,25)(H2,19,20,21,22) QKPOZRFYPBONDJ-UHFFFAOYSA-N 550561 8′-Methyl-6′-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 55 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 0.300 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550561 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550561&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402623 469794563 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162216 Cc1cc(Nc2ncnc3sccc23)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C18H17N5O2S/c1-10-8-12(21-14-11-4-7-26-16(11)20-9-19-14)17(25)23-13(10)15(24)22-18(23)5-2-3-6-18/h4,7-9H,2-3,5-6H2,1H3,(H,22,24)(H,19,20,21) GZFIKYWOQKRTCY-UHFFFAOYSA-N 550562 8′-Methyl-6′-(thieno[2,3-d]pyrimidin-4-ylamino)-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 56 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 0.100 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550562 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550562&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259294 469794564 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162217 Cc1cc(Nc2ccnc3[nH]cnc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C19H20N6O2/c1-11-9-13(23-12-5-8-20-16-14(12)21-10-22-16)18(27)25-15(11)17(26)24-19(25)6-3-2-4-7-19/h5,8-10H,2-4,6-7H2,1H3,(H,24,26)(H2,20,21,22,23) KNJXHDJPZSKTMI-UHFFFAOYSA-N 550563 6′-(3H-Imidazo[4,5-b]pyridin-7-ylamino)-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 57 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 6.20 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550563 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550563&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259265 469794565 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162218 Cc1cc(Nc2ncnc3sc(cc23)C(O)=O)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C19H17N5O4S/c1-9-6-11(17(26)24-13(9)15(25)23-19(24)4-2-3-5-19)22-14-10-7-12(18(27)28)29-16(10)21-8-20-14/h6-8H,2-5H2,1H3,(H,23,25)(H,27,28)(H,20,21,22) PFRJUXJMCVAPMH-UHFFFAOYSA-N 550564 4-[(8′-Methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxylic acid::US11311520, Example 58 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 18.8 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550564&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402542 469794566 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162219 CN(C)CCNC(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCCC5)n4c3=O)ncnc2s1 InChI=1S/C23H27N7O3S/c1-13-10-15(22(33)30-17(13)20(32)28-23(30)6-4-5-7-23)27-18-14-11-16(34-21(14)26-12-25-18)19(31)24-8-9-29(2)3/h10-12H,4-9H2,1-3H3,(H,24,31)(H,28,32)(H,25,26,27) AOGJPMOEFHRZEB-UHFFFAOYSA-N 550565 N-[2-(Dimethylamino)ethyl]-4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 59 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 2.70 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550565 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550565&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259302 469794567 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162220 CN(C)CCN(C)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCCC5)n4c3=O)ncnc2s1 InChI=1S/C24H29N7O3S/c1-14-11-16(22(33)31-18(14)20(32)28-24(31)7-5-6-8-24)27-19-15-12-17(35-21(15)26-13-25-19)23(34)30(4)10-9-29(2)3/h11-13H,5-10H2,1-4H3,(H,28,32)(H,25,26,27) QLBWVZMIZOHDKN-UHFFFAOYSA-N 550566 N-[2-(Dimethylamino)ethyl]-N-methyl-4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 60 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 6.30 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550566 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550566&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259139 469794568 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162221 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2CC(C2)C#N)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C23H21N7O3S/c1-12-6-15(21(32)30-17(12)19(31)28-23(30)4-2-3-5-23)27-18-14-7-16(34-20(14)26-11-25-18)22(33)29-9-13(8-24)10-29/h6-7,11,13H,2-5,9-10H2,1H3,(H,28,31)(H,25,26,27) AVTZSVWIAFBHGI-UHFFFAOYSA-N 550567 1-({4-[(8′-Methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidin-6-yl}carbonyl)azetidine-3-carbonitrile::US11311520, Example 61 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.90 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550567&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146257734 469794569 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162222 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2CC(C2)NC(=O)OC(C)(C)C)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C27H31N7O5S/c1-14-9-17(23(36)34-19(14)21(35)32-27(34)7-5-6-8-27)31-20-16-10-18(40-22(16)29-13-28-20)24(37)33-11-15(12-33)30-25(38)39-26(2,3)4/h9-10,13,15H,5-8,11-12H2,1-4H3,(H,30,38)(H,32,35)(H,28,29,31) JMGPUCXDZVGBSD-UHFFFAOYSA-N 550568 US11311520, Example 62::tert-Butyl [1-({4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidin-6-yl}carbonyl)azetidin-3-yl]carbamate MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 4.00 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550568&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146262128 469794570 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162223 CN(C)[C@@H]1CCN(C1)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCCC5)n4c3=O)ncnc2s1 InChI=1S/C25H29N7O3S/c1-14-10-17(23(34)32-19(14)21(33)29-25(32)7-4-5-8-25)28-20-16-11-18(36-22(16)27-13-26-20)24(35)31-9-6-15(12-31)30(2)3/h10-11,13,15H,4-9,12H2,1-3H3,(H,29,33)(H,26,27,28)/t15-/m1/s1 CDCQKJQVYUUEDH-OAHLLOKOSA-N 550569 6′-[(6-{[(3R)-3-(Dimethylamino)pyrrolidin-1-yl]carbonyl}thieno[2,3-d]pyrimidin-4-yl)amino]-8′-methyl-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 63 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 3.80 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550569&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240067 469794571 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162224 CN(C)C1CCN(CC1)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCCC5)n4c3=O)ncnc2s1 InChI=1S/C26H31N7O3S/c1-15-12-18(24(35)33-20(15)22(34)30-26(33)8-4-5-9-26)29-21-17-13-19(37-23(17)28-14-27-21)25(36)32-10-6-16(7-11-32)31(2)3/h12-14,16H,4-11H2,1-3H3,(H,30,34)(H,27,28,29) FJGODBLRQNMYOH-UHFFFAOYSA-N 550570 6′-[(6-{[4-(Dimethylamino)piperidin-1-yl]carbonyl}thieno[2,3-d]pyrimidin-4-yl)amino]-8′-methyl-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 64 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.50 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550570 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550570&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259096 469794572 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162225 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2C[C@H]3C[C@@H]2CO3)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C24H24N6O4S/c1-12-6-16(22(32)30-18(12)20(31)28-24(30)4-2-3-5-24)27-19-15-8-17(35-21(15)26-11-25-19)23(33)29-9-14-7-13(29)10-34-14/h6,8,11,13-14H,2-5,7,9-10H2,1H3,(H,28,31)(H,25,26,27)/t13-,14-/m1/s1 OFJSXLRXYJZAMH-ZIAGYGMSSA-N 550571 8′-Methyl-6′-({6-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]hept-5-ylcarbonyl]thieno[2,3-d]pyrimidin-4-yl}amino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 65 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.90 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550571 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550571&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402593 469794573 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162226 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2C[C@@H]3C[C@H]2CO3)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C25H26N6O4S/c1-13-7-17(23(33)31-19(13)21(32)29-25(31)5-3-2-4-6-25)28-20-16-9-18(36-22(16)27-12-26-20)24(34)30-10-15-8-14(30)11-35-15/h7,9,12,14-15H,2-6,8,10-11H2,1H3,(H,29,32)(H,26,27,28)/t14-,15-/m0/s1 KGSHUNHSICGGJZ-GJZGRUSLSA-N 550572 8′-Methyl-6′-({6-[(1S,4S)-2-oxa-5-azabicyclo[2.2.1]hept-5-ylcarbonyl]thieno[2,3-d]pyrimidin-4-yl}amino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 66 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 9.00 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550572 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550572&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402609 469794574 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162227 Cc1cc(Nc2ncnc3[nH]cnc23)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C17H17N7O2/c1-9-6-10(22-14-11-13(19-7-18-11)20-8-21-14)16(26)24-12(9)15(25)23-17(24)4-2-3-5-17/h6-8H,2-5H2,1H3,(H,23,25)(H2,18,19,20,21,22) SXRCWZOMTWQHSD-UHFFFAOYSA-N 550573 8′-methyl-6′-(9H-purin-6-ylamino)-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 67 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 0.700 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550573&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402642 469794575 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162228 Cc1cc(Nc2ncnc3[nH]ncc23)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C17H17N7O2/c1-9-6-11(21-13-10-7-20-23-14(10)19-8-18-13)16(26)24-12(9)15(25)22-17(24)4-2-3-5-17/h6-8H,2-5H2,1H3,(H,22,25)(H2,18,19,20,21,23) UYJBKCWXDYENLG-UHFFFAOYSA-N 550574 8′-methyl-6′-(1H-pyrazolo[3,4-d]pyrimidin-4-ylamino)-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 68 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 1.80 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550574 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550574&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146257732 469794576 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162229 Cc1cc(Nc2ncnc3CN(Cc23)S(C)(=O)=O)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C20H24N6O4S/c1-12-8-14(19(28)26-16(12)18(27)24-20(26)6-4-3-5-7-20)23-17-13-9-25(31(2,29)30)10-15(13)21-11-22-17/h8,11H,3-7,9-10H2,1-2H3,(H,24,27)(H,21,22,23) ITMVASXNVDODKU-UHFFFAOYSA-N 550575 8′-methyl-6′-{[6-(methylsulfonyl)-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-yl]amino}-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 69 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 144 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550575&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135258986 469794577 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162230 Cc1cc(Nc2ncnc3CN(Cc23)S(=O)(=O)c2ccccc2)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C25H26N6O4S/c1-16-12-19(24(33)31-21(16)23(32)29-25(31)10-6-3-7-11-25)28-22-18-13-30(14-20(18)26-15-27-22)36(34,35)17-8-4-2-5-9-17/h2,4-5,8-9,12,15H,3,6-7,10-11,13-14H2,1H3,(H,29,32)(H,26,27,28) RTPMXLFKLJOMTP-UHFFFAOYSA-N 550576 8′-methyl-6′-{[6-(phenylsulfonyl)-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-yl]amino}-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 70 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 21.7 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550576 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550576&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402575 469794578 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162231 Cc1cc(Nc2ncnc3CN(Cc23)S(=O)(=O)C(F)F)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C20H22F2N6O4S/c1-11-7-13(18(30)28-15(11)17(29)26-20(28)5-3-2-4-6-20)25-16-12-8-27(33(31,32)19(21)22)9-14(12)23-10-24-16/h7,10,19H,2-6,8-9H2,1H3,(H,26,29)(H,23,24,25) UHAOAUUCIQLVCI-UHFFFAOYSA-N 550577 6′-({6-[(difluoromethyl)sulfonyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-yl}amino)-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 71 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 59.2 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550577&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402637 469794579 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162232 Cc1cc(Nc2ncnc3CN(Cc23)S(=O)(=O)C(F)(F)F)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C20H21F3N6O4S/c1-11-7-13(18(31)29-15(11)17(30)27-19(29)5-3-2-4-6-19)26-16-12-8-28(9-14(12)24-10-25-16)34(32,33)20(21,22)23/h7,10H,2-6,8-9H2,1H3,(H,27,30)(H,24,25,26) IOPLTLSLPBWMOK-UHFFFAOYSA-N 550578 8′-methyl-6′-({6-[(trifluoromethyl)sulfonyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-yl}amino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 72 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 30.4 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550578 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550578&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146257733 469794580 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162233 Cc1cc(Nc2ncnc3CN(Cc23)S(=O)(=O)CC(F)(F)F)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C21H23F3N6O4S/c1-12-7-14(19(32)30-16(12)18(31)28-20(30)5-3-2-4-6-20)27-17-13-8-29(9-15(13)25-11-26-17)35(33,34)10-21(22,23)24/h7,11H,2-6,8-10H2,1H3,(H,28,31)(H,25,26,27) CYDBPOAYBSQSRV-UHFFFAOYSA-N 550579 8′-methyl-6′-({6-[(2,2,2-trifluoroethyl)sulfonyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-yl}amino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 73 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 168 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550579&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259131 469794581 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162234 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2CC(N)C2)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C22H23N7O3S/c1-11-6-14(20(31)29-16(11)18(30)27-22(29)4-2-3-5-22)26-17-13-7-15(33-19(13)25-10-24-17)21(32)28-8-12(23)9-28/h6-7,10,12H,2-5,8-9,23H2,1H3,(H,27,30)(H,24,25,26) JMVNDQOXTUNJTO-UHFFFAOYSA-N 550580 6′-({6-[(3-Aminoazetidin-1-yl)carbonyl]thieno[2,3-d]pyrimidin-4-yl}amino)-8′-methyl-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 74 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 1.50 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550580 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550580&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259129 469794582 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162235 CCNC(=O)N1Cc2ncnc(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)c2C1 InChI=1S/C22H27N7O3/c1-3-23-21(32)28-10-14-16(11-28)24-12-25-18(14)26-15-9-13(2)17-19(30)27-22(29(17)20(15)31)7-5-4-6-8-22/h9,12H,3-8,10-11H2,1-2H3,(H,23,32)(H,27,30)(H,24,25,26) KFXBWJWMDIEDLF-UHFFFAOYSA-N 550581 N-Ethyl-4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide::US11311520, Example 75 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 11.9 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550581 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550581&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146257743 469794583 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162236 CCOC(=O)N1Cc2ncnc(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)c2C1 InChI=1S/C22H26N6O4/c1-3-32-21(31)27-10-14-16(11-27)23-12-24-18(14)25-15-9-13(2)17-19(29)26-22(28(17)20(15)30)7-5-4-6-8-22/h9,12H,3-8,10-11H2,1-2H3,(H,26,29)(H,23,24,25) JCNKQXRIYAANJW-UHFFFAOYSA-N 550582 Ethyl 4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxylate::US11311520, Example 76 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 17.7 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550582&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402647 469794584 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162237 Cc1cc(Nc2ncnc3CN(Cc23)C(=O)[C@@H]2CCC(=O)N2)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C24H27N7O4/c1-13-9-16(23(35)31-19(13)21(33)29-24(31)7-3-2-4-8-24)28-20-14-10-30(11-17(14)25-12-26-20)22(34)15-5-6-18(32)27-15/h9,12,15H,2-8,10-11H2,1H3,(H,27,32)(H,29,33)(H,25,26,28)/t15-/m0/s1 WLPRGHHNGCJIGB-HNNXBMFYSA-N 550583 8′-Methyl-6′-[(6-{[(2S)-5-oxopyrrolidin-2-yl]carbonyl}-6,7-dihydro-5H-pyrrolo[3,4-cl]pyrimidin-4-yl)amino]-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 77 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 55.9 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550583&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259134 469794585 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162238 CC(=O)N1Cc2ncnc(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)c2C1 InChI=1S/C21H24N6O3/c1-12-8-15(24-18-14-9-26(13(2)28)10-16(14)22-11-23-18)20(30)27-17(12)19(29)25-21(27)6-4-3-5-7-21/h8,11H,3-7,9-10H2,1-2H3,(H,25,29)(H,22,23,24) ZRVHATNQTYNBFI-UHFFFAOYSA-N 550584 6′-[(6-Acetyl-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 78 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 37.9 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550584&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259119 469794586 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162239 Cc1cc(Nc2ncnc3CN(Cc23)S(=O)(=O)c2ccccn2)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C24H25N7O4S/c1-15-11-17(23(33)31-20(15)22(32)29-24(31)8-4-2-5-9-24)28-21-16-12-30(13-18(16)26-14-27-21)36(34,35)19-7-3-6-10-25-19/h3,6-7,10-11,14H,2,4-5,8-9,12-13H2,1H3,(H,29,32)(H,26,27,28) SANHRBWMQAEDCG-UHFFFAOYSA-N 550585 8′-Methyl-6′-{[6-(pyridin-2-ylsulfonyl)-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-yl]amino}-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 79 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 122 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550585 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550585&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259112 469794587 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162240 Cc1cc(Nc2ncnc3sc(cc23)C(O)=O)c(=O)n2c1C(=O)NC21CCC(F)(F)CC1 InChI=1S/C20H17F2N5O4S/c1-9-6-11(25-14-10-7-12(18(30)31)32-16(10)24-8-23-14)17(29)27-13(9)15(28)26-20(27)4-2-19(21,22)3-5-20/h6-8H,2-5H2,1H3,(H,26,28)(H,30,31)(H,23,24,25) QRQBMAPEUJOXQT-UHFFFAOYSA-N 550586 4-[(4,4-Difluoro-8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxylic acid::US11311520, Example 80 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 126 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550586 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550586&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402624 469794588 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162241 CN(C)CCNC(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCC(F)(F)CC5)n4c3=O)ncnc2s1 InChI=1S/C24H27F2N7O3S/c1-13-10-15(22(36)33-17(13)20(35)31-24(33)6-4-23(25,26)5-7-24)30-18-14-11-16(37-21(14)29-12-28-18)19(34)27-8-9-32(2)3/h10-12H,4-9H2,1-3H3,(H,27,34)(H,31,35)(H,28,29,30) WQSYFADZIMCZFZ-UHFFFAOYSA-N 550587 4-[(4,4-Difluoro-8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]-N-[2-(dimethylamino)ethyl]thieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 81 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.00 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550587 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550587&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259000 469794589 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162242 CN(C)CCN(C)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCC(F)(F)CC5)n4c3=O)ncnc2s1 InChI=1S/C25H29F2N7O3S/c1-14-11-16(22(36)34-18(14)20(35)31-25(34)7-5-24(26,27)6-8-25)30-19-15-12-17(38-21(15)29-13-28-19)23(37)33(4)10-9-32(2)3/h11-13H,5-10H2,1-4H3,(H,31,35)(H,28,29,30) GDROWJXDECLSSM-UHFFFAOYSA-N 550588 4-[(4,4-Difluoro-8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]-N-[2-(dimethylamino)ethyl]-N-methylthieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 82 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 18.3 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550588 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550588&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259217 469794590 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162243 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2CC(C2)NC(=O)OC(C)(C)C)c(=O)n2c1C(=O)NC21CCC(F)(F)CC1 InChI=1S/C28H31F2N7O5S/c1-14-9-17(23(39)37-19(14)21(38)35-28(37)7-5-27(29,30)6-8-28)34-20-16-10-18(43-22(16)32-13-31-20)24(40)36-11-15(12-36)33-25(41)42-26(2,3)4/h9-10,13,15H,5-8,11-12H2,1-4H3,(H,33,41)(H,35,38)(H,31,32,34) ATUWLKDJACRYFK-UHFFFAOYSA-N 550589 US11311520, Example 83::tert-Butyl [1-({4-[(4,4-difluoro-8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidin-6-yl}carbonyl)azetidin-3-yl]carbamate MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 12.2 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550589 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550589&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259218 469794591 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162244 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2CC(N)C2)c(=O)n2c1C(=O)NC21CCC(F)(F)CC1 InChI=1S/C23H23F2N7O3S/c1-11-6-14(20(34)32-16(11)18(33)30-23(32)4-2-22(24,25)3-5-23)29-17-13-7-15(36-19(13)28-10-27-17)21(35)31-8-12(26)9-31/h6-7,10,12H,2-5,8-9,26H2,1H3,(H,30,33)(H,27,28,29) BBMYOJWRZROCHN-UHFFFAOYSA-N 550590 6′-({6-[(3-Aminoazetidin-1-yl)carbonyl]thieno[2,3-d]pyrimidin-4-yl}amino)-4,4-difluoro-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 84 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 10.8 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550590 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550590&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146257731 469794592 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162245 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2CC(C2)C#N)c(=O)n2c1C(=O)NC21CCC(F)(F)CC1 InChI=1S/C24H21F2N7O3S/c1-12-6-15(21(35)33-17(12)19(34)31-24(33)4-2-23(25,26)3-5-24)30-18-14-7-16(37-20(14)29-11-28-18)22(36)32-9-13(8-27)10-32/h6-7,11,13H,2-5,9-10H2,1H3,(H,31,34)(H,28,29,30) MMYMKUWKANSXDQ-UHFFFAOYSA-N 550591 1-({4-[(4,4-Difluoro-8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidin-6-yl}carbonyl)azetidine-3-carbonitrile::US11311520, Example 85 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 25.2 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550591 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550591&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402595 469794593 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162246 CN(C)[C@@H]1CCN(C1)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCC(F)(F)CC5)n4c3=O)ncnc2s1 InChI=1S/C26H29F2N7O3S/c1-14-10-17(23(37)35-19(14)21(36)32-26(35)7-5-25(27,28)6-8-26)31-20-16-11-18(39-22(16)30-13-29-20)24(38)34-9-4-15(12-34)33(2)3/h10-11,13,15H,4-9,12H2,1-3H3,(H,32,36)(H,29,30,31)/t15-/m1/s1 KIGACDQJOWVRAD-OAHLLOKOSA-N 550592 6′-[(6-{[(3R)-3-(Dimethylamino)pyrrolidin-1-yl]carbonyl}thieno[2,3-d]pyrimidin-4-yl)amino]-4,4-difluoro-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 86 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 11.9 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550592 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550592&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259225 469794594 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162247 CN(C)C1CCN(CC1)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCC(F)(F)CC5)n4c3=O)ncnc2s1 InChI=1S/C27H31F2N7O3S/c1-15-12-18(24(38)36-20(15)22(37)33-27(36)8-6-26(28,29)7-9-27)32-21-17-13-19(40-23(17)31-14-30-21)25(39)35-10-4-16(5-11-35)34(2)3/h12-14,16H,4-11H2,1-3H3,(H,33,37)(H,30,31,32) QLDHZRFKKLGNHK-UHFFFAOYSA-N 550593 6′-[(6-{[4-(Dimethylamino)piperidin-1-yl]carbonyl}thieno[2,3-d]pyrimidin-4-yl)amino]-4,4-difluoro-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 87 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 23.1 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550593 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550593&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259223 469794595 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162248 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2C[C@H]3C[C@@H]2CO3)c(=O)n2c1C(=O)NC21CCC(F)(F)CC1 InChI=1S/C25H24F2N6O4S/c1-12-6-16(22(35)33-18(12)20(34)31-25(33)4-2-24(26,27)3-5-25)30-19-15-8-17(38-21(15)29-11-28-19)23(36)32-9-14-7-13(32)10-37-14/h6,8,11,13-14H,2-5,7,9-10H2,1H3,(H,31,34)(H,28,29,30)/t13-,14-/m1/s1 CXXWJVKJTNDKBR-ZIAGYGMSSA-N 550594 4,4-Difluoro-8′-methyl-6′-({6-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]hept-5-ylcarbonyl]thieno[2,3-d]pyrimidin-4-yl}amino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 88 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 13.5 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550594 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550594&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402570 469794596 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162249 Cc1cc(Nc2ncnc3sccc23)c(=O)n2c1C(=O)NC21CCC(F)(F)CC1 InChI=1S/C19H17F2N5O2S/c1-10-8-12(24-14-11-2-7-29-16(11)23-9-22-14)17(28)26-13(10)15(27)25-19(26)5-3-18(20,21)4-6-19/h2,7-9H,3-6H2,1H3,(H,25,27)(H,22,23,24) ZLNCLNKFFDHJNF-UHFFFAOYSA-N 550595 4,4-Difluoro-8′-methyl-6′-(thieno[2,3-d]pyrimidin-4-ylamino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 89 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 12.8 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550595 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550595&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402531 469794597 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162250 Cc1cc(Nc2ncnc3[nH]ccc23)c(=O)n2c1C(=O)NC21CCC(F)(F)CC1 InChI=1S/C19H18F2N6O2/c1-10-8-12(25-15-11-2-7-22-14(11)23-9-24-15)17(29)27-13(10)16(28)26-19(27)5-3-18(20,21)4-6-19/h2,7-9H,3-6H2,1H3,(H,26,28)(H2,22,23,24,25) OWMQXOZMOZLQFY-UHFFFAOYSA-N 550596 4,4-Difluoro-8′-methyl-6′-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 90::US11311520, Example 91::US11311520, Example 92 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 0.700 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550596 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550596&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259090 469794598 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162251 Cc1cc(Nc2ncnc3[nH]ccc23)c(=O)n2c1C(=O)NC21CCC(F)(F)CC1 InChI=1S/C19H18F2N6O2/c1-10-8-12(25-15-11-2-7-22-14(11)23-9-24-15)17(29)27-13(10)16(28)26-19(27)5-3-18(20,21)4-6-19/h2,7-9H,3-6H2,1H3,(H,26,28)(H2,22,23,24,25) OWMQXOZMOZLQFY-UHFFFAOYSA-N 550596 4,4-Difluoro-8′-methyl-6′-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 90::US11311520, Example 91::US11311520, Example 92 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 1.10 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550596 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550596&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259090 469794598 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162252 Cc1cc(Nc2ncnc3[nH]ccc23)c(=O)n2c1C(=O)NC21CCC(F)(F)CC1 InChI=1S/C19H18F2N6O2/c1-10-8-12(25-15-11-2-7-22-14(11)23-9-24-15)17(29)27-13(10)16(28)26-19(27)5-3-18(20,21)4-6-19/h2,7-9H,3-6H2,1H3,(H,26,28)(H2,22,23,24,25) OWMQXOZMOZLQFY-UHFFFAOYSA-N 550596 4,4-Difluoro-8′-methyl-6′-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 90::US11311520, Example 91::US11311520, Example 92 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 1.20 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550596 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550596&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259090 469794598 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162253 Cc1c(sc2ncnc(Nc3cc(C)c4C(=O)NC5(CCC(F)(F)CC5)n4c3=O)c12)C(O)=O InChI=1S/C21H19F2N5O4S/c1-9-7-11(26-15-12-10(2)14(19(31)32)33-17(12)25-8-24-15)18(30)28-13(9)16(29)27-21(28)5-3-20(22,23)4-6-21/h7-8H,3-6H2,1-2H3,(H,27,29)(H,31,32)(H,24,25,26) PIULAYNXAXTZNV-UHFFFAOYSA-N 550599 4-[(4,4-Difluoro-8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]-5-methylthieno[2,3-d]pyrimidine-6-carboxylic acid::US11311520, Example 93 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 42.0 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550599 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550599&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402559 469794599 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162254 Cc1cc(Nc2ncnc(N)n2)c(=O)n2c1C(=O)NC21CCC(F)(F)CC1 InChI=1S/C16H17F2N7O2/c1-8-6-9(22-14-21-7-20-13(19)23-14)12(27)25-10(8)11(26)24-16(25)4-2-15(17,18)3-5-16/h6-7H,2-5H2,1H3,(H,24,26)(H3,19,20,21,22,23) LLLKCRSOKSDDPH-UHFFFAOYSA-N 550600 6′-[(4-Amino-1,3,5-triazin-2-yl)amino]-4,4-difluoro-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 94 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 27.8 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550600 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550600&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240109 469794600 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162255 Cc1c(sc2ncnc(Nc3cc(C)c4C(=O)NC5(CCCC5)n4c3=O)c12)C(O)=O InChI=1S/C20H19N5O4S/c1-9-7-11(18(27)25-13(9)16(26)24-20(25)5-3-4-6-20)23-15-12-10(2)14(19(28)29)30-17(12)22-8-21-15/h7-8H,3-6H2,1-2H3,(H,24,26)(H,28,29)(H,21,22,23) XQKGRYKSVORWPY-UHFFFAOYSA-N 550601 5-Methyl-4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxylic acid::US11311520, Example 95 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.80 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550601 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550601&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402537 469794601 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162256 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2C[C@H]3C[C@@H]2CO3)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C24H24N6O4S/c1-12-6-16(22(32)30-18(12)20(31)28-24(30)4-2-3-5-24)27-19-15-8-17(35-21(15)26-11-25-19)23(33)29-9-14-7-13(29)10-34-14/h6,8,11,13-14H,2-5,7,9-10H2,1H3,(H,28,31)(H,25,26,27)/t13-,14-/m1/s1 OFJSXLRXYJZAMH-ZIAGYGMSSA-N 550602 8′-Methyl-6′-({6-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]hept-5-ylcarbonyl]thieno[2,3-d]pyrimidin-4-yl}amino)-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 96 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 3.90 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550602 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550602&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402593 469794602 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162257 Cc1cc(Nc2ncnc3sc(cc23)C(N)=O)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C20H20N6O3S/c1-10-7-12(24-16-11-8-13(15(21)27)30-18(11)23-9-22-16)19(29)26-14(10)17(28)25-20(26)5-3-2-4-6-20/h7-9H,2-6H2,1H3,(H2,21,27)(H,25,28)(H,22,23,24) OYTSQSJDXCELPM-UHFFFAOYSA-N 550603 4-[(8′-Methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 97 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.10 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550603 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550603&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402636 469794603 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162258 Cc1cc(Nc2ncnc3ccc(Cl)cc23)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C20H18ClN5O2/c1-11-8-15(24-17-13-9-12(21)4-5-14(13)22-10-23-17)19(28)26-16(11)18(27)25-20(26)6-2-3-7-20/h4-5,8-10H,2-3,6-7H2,1H3,(H,25,27)(H,22,23,24) HTABACXBTQKIIB-UHFFFAOYSA-N 550604 6′-[(6-Chloroquinazolin-4-yl)amino]-8′-methyl-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 98 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 7.60 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550604 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550604&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402640 469794604 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162259 Cc1cc(Nc2ncnc3ccc(Cl)cc23)c(=O)n2c1C(=O)NC21CCC(F)(F)CC1 InChI=1S/C21H18ClF2N5O2/c1-11-8-15(27-17-13-9-12(22)2-3-14(13)25-10-26-17)19(31)29-16(11)18(30)28-21(29)6-4-20(23,24)5-7-21/h2-3,8-10H,4-7H2,1H3,(H,28,30)(H,25,26,27) UWAUJCVYHOSHHY-UHFFFAOYSA-N 550605 6′-[(6-chloroquinazolin-4-yl)amino]-4,4-difluoro-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 99 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 18.8 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550605 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550605&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402554 469794605 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162260 Cc1cc(Nc2ncnc3scnc23)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C17H16N6O2S/c1-9-6-10(21-13-11-15(19-7-18-13)26-8-20-11)16(25)23-12(9)14(24)22-17(23)4-2-3-5-17/h6-8H,2-5H2,1H3,(H,22,24)(H,18,19,21) XHRNNNWAEFKLHG-UHFFFAOYSA-N 550606 8′-Methyl-6′-([1,3]thiazolo[5,4-d]pyrimidin-7-ylamino)-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 100 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 70.5 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550606 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550606&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259117 469794606 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162261 Cc1cc(Nc2ncnc3scnc23)c(=O)n2c1C(=O)NC21CCC(F)(F)CC1 InChI=1S/C18H16F2N6O2S/c1-9-6-10(24-13-11-15(22-7-21-13)29-8-23-11)16(28)26-12(9)14(27)25-18(26)4-2-17(19,20)3-5-18/h6-8H,2-5H2,1H3,(H,25,27)(H,21,22,24) GTEXHLQQVKQBSP-UHFFFAOYSA-N 550607 4,4-Difluoro-8′-methyl-6′-([1,3]thiazolo[5,4-d]pyrimidin-7-ylamino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 101 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 187 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550607 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550607&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259012 469794607 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162262 Cc1cc(Nc2ncnc3sc(cc23)C(N)=O)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C19H18N6O3S/c1-9-6-11(18(28)25-13(9)16(27)24-19(25)4-2-3-5-19)23-15-10-7-12(14(20)26)29-17(10)22-8-21-15/h6-8H,2-5H2,1H3,(H2,20,26)(H,24,27)(H,21,22,23) GJMRBQWMPKWPTH-UHFFFAOYSA-N 550608 4-[(8′-Methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 102 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.70 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550608 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550608&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259315 469794608 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162263 Cc1cc(Nc2ncnc3CN(Cc23)C(=O)OC(C)(C)C)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C23H28N6O4/c1-13-9-15(20(31)29-17(13)19(30)27-23(29)7-5-6-8-23)26-18-14-10-28(11-16(14)24-12-25-18)21(32)33-22(2,3)4/h9,12H,5-8,10-11H2,1-4H3,(H,27,30)(H,24,25,26) IIFCGXQZWDWAPW-UHFFFAOYSA-N 550609 US11311520, Example 103::tert-Butyl 4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxylate MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 4.70 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550609 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550609&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402601 469794609 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162264 Cc1cc(Nc2ncnc3CN(Cc23)C(=O)OC(C)(C)C)c(=O)n2c1C(=O)NC21CCC(F)(F)CC1 InChI=1S/C24H28F2N6O4/c1-13-9-15(20(34)32-17(13)19(33)30-24(32)7-5-23(25,26)6-8-24)29-18-14-10-31(11-16(14)27-12-28-18)21(35)36-22(2,3)4/h9,12H,5-8,10-11H2,1-4H3,(H,30,33)(H,27,28,29) HHOREVJXVMFOEA-UHFFFAOYSA-N 550610 US11311520, Example 104::tert-Butyl 4-[(4,4-difluoro-8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxylate MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 30.2 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550610 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550610&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402599 469794610 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162265 Cc1cc(Nc2ncnc3[nH]ncc23)c(=O)n2c1C(=O)NC21CCC(F)(F)CC1 InChI=1S/C18H17F2N7O2/c1-9-6-11(24-13-10-7-23-26-14(10)22-8-21-13)16(29)27-12(9)15(28)25-18(27)4-2-17(19,20)3-5-18/h6-8H,2-5H2,1H3,(H,25,28)(H2,21,22,23,24,26) UXIBXDPWXQCUBO-UHFFFAOYSA-N 550611 4,4-Difluoro-8′-methyl-6′-(1H-pyrazolo[3,4-d]pyrimidin-4-ylamino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 105 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 8.30 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550611 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550611&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259320 469794611 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162266 Cc1cc(Nc2ncnc3[nH]cnc23)c(=O)n2c1C(=O)NC21CCC(F)(F)CC1 InChI=1S/C18H17F2N7O2/c1-9-6-10(25-14-11-13(22-7-21-11)23-8-24-14)16(29)27-12(9)15(28)26-18(27)4-2-17(19,20)3-5-18/h6-8H,2-5H2,1H3,(H,26,28)(H2,21,22,23,24,25) OKOSYFPDIIDJAP-UHFFFAOYSA-N 550612 4,4-Difluoro-8′-methyl-6′-(9H-purin-6-ylamino)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 106 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 3.50 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550612 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550612&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259014 469794612 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162267 Cc1c(sc2ncnc(Nc3cc(C)c4C(=O)NC5(CCCC5)n4c3=O)c12)C(N)=O InChI=1S/C20H20N6O3S/c1-9-7-11(19(29)26-13(9)17(28)25-20(26)5-3-4-6-20)24-16-12-10(2)14(15(21)27)30-18(12)23-8-22-16/h7-8H,3-6H2,1-2H3,(H2,21,27)(H,25,28)(H,22,23,24) DIEMADVGOHCCOX-UHFFFAOYSA-N 550613 5-Methyl-4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 107 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 111 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550613 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550613&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135258987 469794613 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162268 Cc1cc(Nc2ncnc3cc(Cl)ccc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C21H20ClN5O2/c1-12-9-16(25-18-14-6-5-13(22)10-15(14)23-11-24-18)20(29)27-17(12)19(28)26-21(27)7-3-2-4-8-21/h5-6,9-11H,2-4,7-8H2,1H3,(H,26,28)(H,23,24,25) YDOYXFNDGOQERP-UHFFFAOYSA-N 550614 6′-[(7-Chloroquinazolin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 108 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 16.5 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550614 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550614&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259137 469794614 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162269 Cc1cc(Nc2ncnc3cccc(Cl)c23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C21H20ClN5O2/c1-12-10-15(25-18-16-13(22)6-5-7-14(16)23-11-24-18)20(29)27-17(12)19(28)26-21(27)8-3-2-4-9-21/h5-7,10-11H,2-4,8-9H2,1H3,(H,26,28)(H,23,24,25) CGMUGJSZDJSGRH-UHFFFAOYSA-N 550615 6′-[(5-Chloroquinazolin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 109 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 10.2 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550615 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550615&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259006 469794615 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162270 Cc1cc(Nc2ncnc3c(Cl)cc(Cl)cc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C21H19Cl2N5O2/c1-11-7-15(26-18-13-8-12(22)9-14(23)16(13)24-10-25-18)20(30)28-17(11)19(29)27-21(28)5-3-2-4-6-21/h7-10H,2-6H2,1H3,(H,27,29)(H,24,25,26) JCCZJSOFHHOYQN-UHFFFAOYSA-N 550616 6′-[(6,8-Dichloroquinazolin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 110 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5580 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550616 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550616&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259298 469794616 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162271 Cc1cc(Nc2ncnc3c(F)cccc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C21H20FN5O2/c1-12-10-15(25-18-13-6-5-7-14(22)16(13)23-11-24-18)20(29)27-17(12)19(28)26-21(27)8-3-2-4-9-21/h5-7,10-11H,2-4,8-9H2,1H3,(H,26,28)(H,23,24,25) USKJBDJEWVFPGQ-UHFFFAOYSA-N 550617 6′-[(8-Fluoroquinazolin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 111 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 517 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550617 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550617&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259222 469794617 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162272 Cc1cc(Nc2ncnc3cc(F)ccc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C21H20FN5O2/c1-12-9-16(25-18-14-6-5-13(22)10-15(14)23-11-24-18)20(29)27-17(12)19(28)26-21(27)7-3-2-4-8-21/h5-6,9-11H,2-4,7-8H2,1H3,(H,26,28)(H,23,24,25) SZPAHVHNZHLKDQ-UHFFFAOYSA-N 550618 6′-[(7-Fluoroquinazolin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 112 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 25.3 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550618 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550618&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259212 469794618 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162273 Cc1cc(Nc2ncnc3ccc(F)cc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C21H20FN5O2/c1-12-9-16(25-18-14-10-13(22)5-6-15(14)23-11-24-18)20(29)27-17(12)19(28)26-21(27)7-3-2-4-8-21/h5-6,9-11H,2-4,7-8H2,1H3,(H,26,28)(H,23,24,25) MNEMPCGKBGLJSS-UHFFFAOYSA-N 550619 6′-[(6-Fluoroquinazolin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 113 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 15.4 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550619 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550619&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259005 469794619 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162274 Cc1cc(Nc2ncnc3cc(F)cc(F)c23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C21H19F2N5O2/c1-11-7-15(26-18-16-13(23)8-12(22)9-14(16)24-10-25-18)20(30)28-17(11)19(29)27-21(28)5-3-2-4-6-21/h7-10H,2-6H2,1H3,(H,27,29)(H,24,25,26) XZZFVALNZYOYAC-UHFFFAOYSA-N 550620 6′-[(5,7-Difluoroquinazolin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 114 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 8.60 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550620 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550620&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259224 469794620 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162275 Cc1cc(Nc2ncnc3c(F)c(F)ccc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C21H19F2N5O2/c1-11-9-14(26-18-12-5-6-13(22)15(23)16(12)24-10-25-18)20(30)28-17(11)19(29)27-21(28)7-3-2-4-8-21/h5-6,9-10H,2-4,7-8H2,1H3,(H,27,29)(H,24,25,26) QZLRFTMULBLZEB-UHFFFAOYSA-N 550621 6′-[(7,8-Difluoroquinazolin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 115 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 208 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550621 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550621&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259184 469794621 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162276 COc1ccc2c(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)ncnc2c1 InChI=1S/C22H23N5O3/c1-13-10-17(25-19-15-7-6-14(30-2)11-16(15)23-12-24-19)21(29)27-18(13)20(28)26-22(27)8-4-3-5-9-22/h6-7,10-12H,3-5,8-9H2,1-2H3,(H,26,28)(H,23,24,25) MEQNUBZEWIKJRL-UHFFFAOYSA-N 550622 6′-[(7-Methoxyquinazolin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 116 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 4.00 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550622 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550622&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259180 469794622 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162277 COc1ccc2ncnc(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)c2c1 InChI=1S/C22H23N5O3/c1-13-10-17(25-19-15-11-14(30-2)6-7-16(15)23-12-24-19)21(29)27-18(13)20(28)26-22(27)8-4-3-5-9-22/h6-7,10-12H,3-5,8-9H2,1-2H3,(H,26,28)(H,23,24,25) YRTCXORQEZMMPU-UHFFFAOYSA-N 550623 6′-[(6-Methoxyquinazolin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 117 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 12.5 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550623 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550623&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259113 469794623 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162278 COc1cccc2ncnc(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)c12 InChI=1S/C22H23N5O3/c1-13-11-15(25-19-17-14(23-12-24-19)7-6-8-16(17)30-2)21(29)27-18(13)20(28)26-22(27)9-4-3-5-10-22/h6-8,11-12H,3-5,9-10H2,1-2H3,(H,26,28)(H,23,24,25) IEQYTJULDPUJKK-UHFFFAOYSA-N 550624 6′-[(5-Methoxyquinazolin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 118 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 66.3 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550624 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550624&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259250 469794624 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162279 COc1cc2ncnc(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)c2cc1OC InChI=1S/C23H25N5O4/c1-13-9-16(22(30)28-19(13)21(29)27-23(28)7-5-4-6-8-23)26-20-14-10-17(31-2)18(32-3)11-15(14)24-12-25-20/h9-12H,4-8H2,1-3H3,(H,27,29)(H,24,25,26) VHNRIAXPJOWAIU-UHFFFAOYSA-N 550625 6′-[(6,7-Dimethoxyquinazolin-4-yl)amino]-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 119 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 3.00 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550625 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550625&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259284 469794625 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162280 Cc1cc(Nc2ncnc3c(C)cccc23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C22H23N5O2/c1-13-7-6-8-15-17(13)23-12-24-19(15)25-16-11-14(2)18-20(28)26-22(27(18)21(16)29)9-4-3-5-10-22/h6-8,11-12H,3-5,9-10H2,1-2H3,(H,26,28)(H,23,24,25) JVOVLOXFZMPIKY-UHFFFAOYSA-N 550626 8′-methyl-6′-[(8-methylquinazolin-4-yl)amino]-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 120 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens >20000 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550626 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550626&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259318 469794626 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162281 Cc1ccc2c(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)ncnc2c1 InChI=1S/C22H23N5O2/c1-13-6-7-15-16(10-13)23-12-24-19(15)25-17-11-14(2)18-20(28)26-22(27(18)21(17)29)8-4-3-5-9-22/h6-7,10-12H,3-5,8-9H2,1-2H3,(H,26,28)(H,23,24,25) ZESWWDJKUMILGN-UHFFFAOYSA-N 550627 8′-Methyl-6′-[(7-methylquinazolin-4-yl)amino]-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 121 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 7.10 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550627 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550627&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259092 469794627 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162282 Cc1ccc2ncnc(Nc3cc(C)c4C(=O)NC5(CCCCC5)n4c3=O)c2c1 InChI=1S/C22H23N5O2/c1-13-6-7-16-15(10-13)19(24-12-23-16)25-17-11-14(2)18-20(28)26-22(27(18)21(17)29)8-4-3-5-9-22/h6-7,10-12H,3-5,8-9H2,1-2H3,(H,26,28)(H,23,24,25) QYTHFUXQLQOLDO-UHFFFAOYSA-N 550628 8′-Methyl-6′-[(6-methylquinazolin-4-yl)amino]-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 122 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 13.2 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550628 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550628&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259182 469794628 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162283 Cc1cc(Nc2ncnc3cccc(C)c23)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C22H23N5O2/c1-13-7-6-8-15-17(13)19(24-12-23-15)25-16-11-14(2)18-20(28)26-22(27(18)21(16)29)9-4-3-5-10-22/h6-8,11-12H,3-5,9-10H2,1-2H3,(H,26,28)(H,23,24,25) KCSHBDRVYMYYDM-UHFFFAOYSA-N 550629 8′-Methyl-6′-[(5-methylquinazolin-4-yl)amino]-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 123 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 9.70 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550629 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550629&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259152 469794629 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162284 Cc1cc(Nc2ncnc3ccc(cc23)C(F)(F)F)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C22H20F3N5O2/c1-12-9-16(20(32)30-17(12)19(31)29-21(30)7-3-2-4-8-21)28-18-14-10-13(22(23,24)25)5-6-15(14)26-11-27-18/h5-6,9-11H,2-4,7-8H2,1H3,(H,29,31)(H,26,27,28) NZRRVDKGRXMHPX-UHFFFAOYSA-N 550630 8′-Methyl-6′-{[6-(trifluoromethyl)quinazolin-4-yl]amino}-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 124 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 49.9 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550630 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550630&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146257748 469794630 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162285 Cc1cc(Nc2ncnc3CNCc23)c(=O)n2c1C(=O)NC21CCC(F)(F)CC1 InChI=1S/C19H20F2N6O2/c1-10-6-12(25-15-11-7-22-8-13(11)23-9-24-15)17(29)27-14(10)16(28)26-19(27)4-2-18(20,21)3-5-19/h6,9,22H,2-5,7-8H2,1H3,(H,26,28)(H,23,24,25) MYQCECYNKPPBCO-UHFFFAOYSA-N 550631 6′-(6,7-Dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-ylamino)-4,4-difluoro-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 125 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 46.5 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550631 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550631&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402555 469794631 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162286 Cc1cc(Nc2ncnc3CNCc23)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C18H20N6O2/c1-10-6-12(22-15-11-7-19-8-13(11)20-9-21-15)17(26)24-14(10)16(25)23-18(24)4-2-3-5-18/h6,9,19H,2-5,7-8H2,1H3,(H,23,25)(H,20,21,22) SCDDFTFBKAHLDS-UHFFFAOYSA-N 550632 6′-(6,7-Dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-ylamino)-8′-methyl-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 126 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 20.3 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550632 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550632&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259186 469794632 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162287 Cc1cc(Nc2ncnc(N)n2)c(=O)n2c1C(=O)NC21CCC(O)(CC1)C(F)(F)F InChI=1S/C17H18F3N7O3/c1-8-6-9(24-14-23-7-22-13(21)25-14)12(29)27-10(8)11(28)26-16(27)4-2-15(30,3-5-16)17(18,19)20/h6-7,30H,2-5H2,1H3,(H,26,28)(H3,21,22,23,24,25) HRTPGAXURJTPGQ-UHFFFAOYSA-N 550633 6′-[(4-Amino-1,3,5-triazin-2-yl)amino]-4-hydroxy-8′-methyl-4-(trifluoromethyl)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 127 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 71.2 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550633 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550633&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259155 469794633 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162288 Cc1cc(Nc2ncnc3[nH]ccc23)c(=O)n2c1C(=O)NC21CCC(O)(CC1)C(F)(F)F InChI=1S/C20H19F3N6O3/c1-10-8-12(27-15-11-2-7-24-14(11)25-9-26-15)17(31)29-13(10)16(30)28-19(29)5-3-18(32,4-6-19)20(21,22)23/h2,7-9,32H,3-6H2,1H3,(H,28,30)(H2,24,25,26,27) CCIPCBNFMZATCF-UHFFFAOYSA-N 550634 4-Hydroxy-8′-methyl-6′-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-4-(trifluoromethyl)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 128 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 1.000 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550634 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550634&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259022 469794634 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162289 CN(C)CCNC(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCC(O)(CC5)C(F)(F)F)n4c3=O)ncnc2s1 InChI=1S/C25H28F3N7O4S/c1-13-10-15(32-18-14-11-16(40-21(14)31-12-30-18)19(36)29-8-9-34(2)3)22(38)35-17(13)20(37)33-24(35)6-4-23(39,5-7-24)25(26,27)28/h10-12,39H,4-9H2,1-3H3,(H,29,36)(H,33,37)(H,30,31,32) DNZVROGIPVKCCJ-UHFFFAOYSA-N 550635 N-[2-(Dimethylamino)ethyl]-4-{[4-hydroxy-8′-methyl-1′,5′-dioxo-4-(trifluoromethyl)-1′,5′-dihydro-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridin]-6′-yl]amino}thieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 129 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 21.0 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550635 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550635&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402547 469794635 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162290 Cc1cc(Nc2ncnc3sccc23)c(=O)n2c1C(=O)NC21CCC(O)(CC1)C(F)(F)F InChI=1S/C20H18F3N5O3S/c1-10-8-12(26-14-11-2-7-32-16(11)25-9-24-14)17(30)28-13(10)15(29)27-19(28)5-3-18(31,4-6-19)20(21,22)23/h2,7-9,31H,3-6H2,1H3,(H,27,29)(H,24,25,26) GLWDPOWKTXLXKD-UHFFFAOYSA-N 550636 4-Hydroxy-8′-methyl-6′-(thieno[2,3-d]pyrimidin-4-ylamino)-4-(trifluoromethyl)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 130 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 7.90 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550636 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550636&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259102 469794636 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162291 Cc1cc(Nc2ncnc(N)n2)c(=O)n2c1C(=O)NC2(C)C InChI=1S/C13H15N7O2/c1-6-4-7(17-12-16-5-15-11(14)18-12)10(22)20-8(6)9(21)19-13(20,2)3/h4-5H,1-3H3,(H,19,21)(H3,14,15,16,17,18) YJCHWVWKJUQQFJ-UHFFFAOYSA-N 550637 6-[(4-Amino-1,3,5-triazin-2-yl)amino]-3,3,8-trimethyl-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione::US11311520, Example 131 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 32.2 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550637 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550637&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402545 469794637 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162292 Cc1cc(Nc2ncnc3[nH]ccc23)c(=O)n2c1C(=O)NC2(C)C InChI=1S/C16H16N6O2/c1-8-6-10(15(24)22-11(8)14(23)21-16(22,2)3)20-13-9-4-5-17-12(9)18-7-19-13/h4-7H,1-3H3,(H,21,23)(H2,17,18,19,20) RYCDBDXOVCKXPI-UHFFFAOYSA-N 550638 3,3,8-Trimethyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione::US11311520, Example 132 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 0.700 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550638 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550638&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146257741 469794638 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162293 Cc1cc(Nc2ncnc3[nH]ncc23)c(=O)n2c1C(=O)NC2(C)C InChI=1S/C15H15N7O2/c1-7-4-9(14(24)22-10(7)13(23)20-15(22,2)3)19-11-8-5-18-21-12(8)17-6-16-11/h4-6H,1-3H3,(H,20,23)(H2,16,17,18,19,21) YVMLJLUYSMFRHI-UHFFFAOYSA-N 550639 3,3,8-Trimethyl-6-(1H-pyrazolo[3,4-d]pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione::US11311520, Example 133 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 10.1 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550639 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550639&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240039 469794639 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162294 Cc1cc(Nc2ncnc3[nH]cnc23)c(=O)n2c1C(=O)NC2(C)C InChI=1S/C15H15N7O2/c1-7-4-8(14(24)22-10(7)13(23)21-15(22,2)3)20-12-9-11(17-5-16-9)18-6-19-12/h4-6H,1-3H3,(H,21,23)(H2,16,17,18,19,20) ZYVHHLHDXWOANG-UHFFFAOYSA-N 550640 3,3,8-Trimethyl-6-(9H-purin-6-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione::US11311520, Example 134 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.80 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550640 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550640&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240052 469794640 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162295 Cc1cc(Nc2ncnc3sccc23)c(=O)n2c1C(=O)NC2(C)C InChI=1S/C16H15N5O2S/c1-8-6-10(15(23)21-11(8)13(22)20-16(21,2)3)19-12-9-4-5-24-14(9)18-7-17-12/h4-7H,1-3H3,(H,20,22)(H,17,18,19) FQTIRTUZLDYJQW-UHFFFAOYSA-N 550641 3,3,8-Trimethyl-6-(thieno[2,3-d]pyrimidin-4-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione::US11311520, Example 135 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 19.8 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550641 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550641&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240218 469794641 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162296 Cc1cc(Nc2ncnc3sc(cc23)C(O)=O)c(=O)n2c1C(=O)NC2(C)C InChI=1S/C17H15N5O4S/c1-7-4-9(15(24)22-11(7)13(23)21-17(22,2)3)20-12-8-5-10(16(25)26)27-14(8)19-6-18-12/h4-6H,1-3H3,(H,21,23)(H,25,26)(H,18,19,20) CFZLFJPSRIHMST-UHFFFAOYSA-N 550642 4-[(3,3,8-Trimethyl-1,5-dioxo-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino]thieno[2,3-d]pyrimidine-6-carboxylic acid::US11311520, Example 136 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 122 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550642 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550642&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240053 469794642 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162297 CN(C)CCNC(=O)c1cc2c(Nc3cc(C)c4C(=O)NC(C)(C)n4c3=O)ncnc2s1 InChI=1S/C21H25N7O3S/c1-11-8-13(20(31)28-15(11)18(30)26-21(28,2)3)25-16-12-9-14(32-19(12)24-10-23-16)17(29)22-6-7-27(4)5/h8-10H,6-7H2,1-5H3,(H,22,29)(H,26,30)(H,23,24,25) WGRQDJRAUREYAY-UHFFFAOYSA-N 550643 N-[2-(Dimethylamino)ethyl]-4-[(3,3,8-trimethyl-1,5-dioxo-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino]thieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 137 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 21.1 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550643 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550643&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240038 469794643 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162298 CN(C)CCN(C)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC(C)(C)n4c3=O)ncnc2s1 InChI=1S/C22H27N7O3S/c1-12-9-14(20(31)29-16(12)18(30)26-22(29,2)3)25-17-13-10-15(33-19(13)24-11-23-17)21(32)28(6)8-7-27(4)5/h9-11H,7-8H2,1-6H3,(H,26,30)(H,23,24,25) ZKOPZCUVHOJFBW-UHFFFAOYSA-N 550644 N-[2-(Dimethylamino)ethyl]-N-methyl-4-[(3,3,8-trimethyl-1,5-dioxo-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino]thieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 138 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 33.6 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550644 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550644&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240105 469794644 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162299 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2CC(C2)NC(=O)OC(C)(C)C)c(=O)n2c1C(=O)NC2(C)C InChI=1S/C25H29N7O5S/c1-12-7-15(21(34)32-17(12)19(33)30-25(32,5)6)29-18-14-8-16(38-20(14)27-11-26-18)22(35)31-9-13(10-31)28-23(36)37-24(2,3)4/h7-8,11,13H,9-10H2,1-6H3,(H,28,36)(H,30,33)(H,26,27,29) PYCFREIOECZPPJ-UHFFFAOYSA-N 550645 US11311520, Example 139::tert-Butyl [1-({4-[(3,3,8-trimethyl-1,5-dioxo-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino]thieno[2,3-d]pyrimidin-6-yl}carbonyl)azetidin-3-yl]carbamate MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 24.1 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550645 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550645&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259229 469794645 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162300 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2CC(N)C2)c(=O)n2c1C(=O)NC2(C)C InChI=1S/C20H21N7O3S/c1-9-4-12(18(29)27-14(9)16(28)25-20(27,2)3)24-15-11-5-13(31-17(11)23-8-22-15)19(30)26-6-10(21)7-26/h4-5,8,10H,6-7,21H2,1-3H3,(H,25,28)(H,22,23,24) FILWXXKGZOXFLW-UHFFFAOYSA-N 550646 6-({6-[(3-Aminoazetidin-1-yl)carbonyl]thieno[2,3-d]pyrimidin-4-yl}amino)-3,3,8-trimethyl-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione::US11311520, Example 140 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 22.3 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550646 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550646&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240080 469794646 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162301 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2CC(C2)C#N)c(=O)n2c1C(=O)NC2(C)C InChI=1S/C21H19N7O3S/c1-10-4-13(19(30)28-15(10)17(29)26-21(28,2)3)25-16-12-5-14(32-18(12)24-9-23-16)20(31)27-7-11(6-22)8-27/h4-5,9,11H,7-8H2,1-3H3,(H,26,29)(H,23,24,25) LIKNNUHHWIWGAA-UHFFFAOYSA-N 550647 1-({4-[(3,3,8-Trimethyl-1,5-dioxo-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino]thieno[2,3-d]pyrimidin-6-yl}carbonyl)azetidine-3-carbonitrile::US11311520, Example 141 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 24.2 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550647 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550647&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240055 469794647 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162302 CN(C)[C@@H]1CCN(C1)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC(C)(C)n4c3=O)ncnc2s1 InChI=1S/C23H27N7O3S/c1-12-8-15(21(32)30-17(12)19(31)27-23(30,2)3)26-18-14-9-16(34-20(14)25-11-24-18)22(33)29-7-6-13(10-29)28(4)5/h8-9,11,13H,6-7,10H2,1-5H3,(H,27,31)(H,24,25,26)/t13-/m1/s1 FIPADWPXHLZBAG-CYBMUJFWSA-N 550648 6-[(6-{[(3R)-3-(Dimethylamino)pyrrolidin-1-yl]carbonyl}thieno[2,3-d]pyrimidin-4-yl)amino]-3,3,8-trimethyl-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione::US11311520, Example 142 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 20.0 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550648 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550648&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240051 469794648 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162303 CN(C)C1CCN(CC1)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC(C)(C)n4c3=O)ncnc2s1 InChI=1S/C24H29N7O3S/c1-13-10-16(22(33)31-18(13)20(32)28-24(31,2)3)27-19-15-11-17(35-21(15)26-12-25-19)23(34)30-8-6-14(7-9-30)29(4)5/h10-12,14H,6-9H2,1-5H3,(H,28,32)(H,25,26,27) BEKSEOHUQWEXRN-UHFFFAOYSA-N 550649 6-[(6-{[4-(Dimethylamino)piperidin-1-yl]carbonyl}thieno[2,3-d]pyrimidin-4-yl)amino]-3,3,8-trimethyl-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione::US11311520, Example 143 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 40.3 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550649 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550649&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402544 469794649 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162304 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2C[C@H]3C[C@@H]2CO3)c(=O)n2c1C(=O)NC2(C)C InChI=1S/C22H22N6O4S/c1-10-4-14(20(30)28-16(10)18(29)26-22(28,2)3)25-17-13-6-15(33-19(13)24-9-23-17)21(31)27-7-12-5-11(27)8-32-12/h4,6,9,11-12H,5,7-8H2,1-3H3,(H,26,29)(H,23,24,25)/t11-,12-/m1/s1 OXLUVNKEKKBUAB-VXGBXAGGSA-N 550650 3,3,8-Trimethyl-6-({6-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]hept-5-ylcarbonyl]thieno[2,3-d]pyrimidin-4-yl}amino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione::US11311520, Example 144 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 12.9 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550650 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550650&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240061 469794650 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162305 Cc1c(sc2ncnc(Nc3cc(C)c4C(=O)NC(C)(C)n4c3=O)c12)C(O)=O InChI=1S/C18H17N5O4S/c1-7-5-9(16(25)23-11(7)14(24)22-18(23,3)4)21-13-10-8(2)12(17(26)27)28-15(10)20-6-19-13/h5-6H,1-4H3,(H,22,24)(H,26,27)(H,19,20,21) FLXBQKFOOAPBQE-UHFFFAOYSA-N 550651 5-Methyl-4-[(3,3,8-trimethyl-1,5-dioxo-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino]thieno[2,3-d]pyrimidine-6-carboxylic acid::US11311520, Example 145 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 115 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550651 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550651&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240049 469794651 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162306 Cc1cc(Nc2ncnc(NC(=O)C3CC3)n2)c(=O)n2c1C(=O)NC21CCC1 InChI=1S/C18H19N7O3/c1-9-7-11(15(28)25-12(9)14(27)24-18(25)5-2-6-18)21-16-19-8-20-17(23-16)22-13(26)10-3-4-10/h7-8,10H,2-6H2,1H3,(H,24,27)(H2,19,20,21,22,23,26) SONXMEHXGNCVCS-UHFFFAOYSA-N 550652 N-{4-[(8′-Methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]-1,3,5-triazin-2-yl}cyclopropanecarboxamide::US11311520, Example 146 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 8.20 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550652 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550652&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259183 469794652 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162307 Cc1cc(Nc2ncnc(N)n2)c(=O)n2c1C(=O)NC21CCC1 InChI=1S/C14H15N7O2/c1-7-5-8(18-13-17-6-16-12(15)19-13)11(23)21-9(7)10(22)20-14(21)3-2-4-14/h5-6H,2-4H2,1H3,(H,20,22)(H3,15,16,17,18,19) UGUGXGWFLROVKB-UHFFFAOYSA-N 550653 6′-[(4-Amino-1,3,5-triazin-2-yl)amino]-8′-methyl-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 147 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 12.7 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550653 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550653&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259257 469794653 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162308 Cc1cc(Nc2ncnc3[nH]ccc23)c(=O)n2c1C(=O)NC21CCC1 InChI=1S/C17H16N6O2/c1-9-7-11(21-14-10-3-6-18-13(10)19-8-20-14)16(25)23-12(9)15(24)22-17(23)4-2-5-17/h3,6-8H,2,4-5H2,1H3,(H,22,24)(H2,18,19,20,21) QCJGDUYOWBJFHZ-UHFFFAOYSA-N 550654 8′-Methyl-6′-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 148 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 0.400 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550654 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550654&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259146 469794654 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162309 Cc1cc(Nc2ncnc3sccc23)c(=O)n2c1C(=O)NC21CCC1 InChI=1S/C17H15N5O2S/c1-9-7-11(20-13-10-3-6-25-15(10)19-8-18-13)16(24)22-12(9)14(23)21-17(22)4-2-5-17/h3,6-8H,2,4-5H2,1H3,(H,21,23)(H,18,19,20) INFKNVOKKIXEMO-UHFFFAOYSA-N 550655 8′-Methyl-6′-(thieno[2,3-d]pyrimidin-4-ylamino)-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 149 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 2.30 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550655 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550655&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259016 469794655 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162310 Cc1cc(Nc2ncnc3sc(cc23)C(O)=O)c(=O)n2c1C(=O)NC21CCC1 InChI=1S/C18H15N5O4S/c1-8-5-10(16(25)23-12(8)14(24)22-18(23)3-2-4-18)21-13-9-6-11(17(26)27)28-15(9)20-7-19-13/h5-7H,2-4H2,1H3,(H,22,24)(H,26,27)(H,19,20,21) QHQGGPWQJTYCCT-UHFFFAOYSA-N 550656 4-[(8′-Methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxylic acid::US11311520, Example 150 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 18.5 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550656 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550656&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240336 469794656 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162311 CN(C)CCNC(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCC5)n4c3=O)ncnc2s1 InChI=1S/C22H25N7O3S/c1-12-9-14(21(32)29-16(12)19(31)27-22(29)5-4-6-22)26-17-13-10-15(33-20(13)25-11-24-17)18(30)23-7-8-28(2)3/h9-11H,4-8H2,1-3H3,(H,23,30)(H,27,31)(H,24,25,26) GTVCKQXVBDFONH-UHFFFAOYSA-N 550657 N-[2-(Dimethylamino)ethyl]-4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 151 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 4.00 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550657 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550657&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259322 469794657 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162312 CN(C)CCN(C)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCC5)n4c3=O)ncnc2s1 InChI=1S/C23H27N7O3S/c1-13-10-15(21(32)30-17(13)19(31)27-23(30)6-5-7-23)26-18-14-11-16(34-20(14)25-12-24-18)22(33)29(4)9-8-28(2)3/h10-12H,5-9H2,1-4H3,(H,27,31)(H,24,25,26) ZEXLNWQUWFGION-UHFFFAOYSA-N 550658 N-[2-(Dimethylamino)ethyl]-N-methyl-4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxamide::US11311520, Example 152 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 7.40 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550658 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550658&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259156 469794658 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162313 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2CC(C2)NC(=O)OC(C)(C)C)c(=O)n2c1C(=O)NC21CCC1 InChI=1S/C26H29N7O5S/c1-13-8-16(22(35)33-18(13)20(34)31-26(33)6-5-7-26)30-19-15-9-17(39-21(15)28-12-27-19)23(36)32-10-14(11-32)29-24(37)38-25(2,3)4/h8-9,12,14H,5-7,10-11H2,1-4H3,(H,29,37)(H,31,34)(H,27,28,30) FIPPCKFDFHBKRY-UHFFFAOYSA-N 550659 US11311520, Example 153::tert-Butyl [1-({4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidin-6-yl}carbonyl)azetidin-3-yl]carbamate MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.30 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550659&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259106 469794659 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162314 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2CC(N)C2)c(=O)n2c1C(=O)NC21CCC1 InChI=1S/C21H21N7O3S/c1-10-5-13(19(30)28-15(10)17(29)26-21(28)3-2-4-21)25-16-12-6-14(32-18(12)24-9-23-16)20(31)27-7-11(22)8-27/h5-6,9,11H,2-4,7-8,22H2,1H3,(H,26,29)(H,23,24,25) DPOSWZIBAJZQQB-UHFFFAOYSA-N 550660 6′-({6-[(3-Aminoazetidin-1-yl)carbonyl]thieno[2,3-d]pyrimidin-4-yl}amino)-8′-methyl-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 154 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.00 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550660 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550660&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259256 469794660 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162315 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2CC(C2)C#N)c(=O)n2c1C(=O)NC21CCC1 InChI=1S/C22H19N7O3S/c1-11-5-14(20(31)29-16(11)18(30)27-22(29)3-2-4-22)26-17-13-6-15(33-19(13)25-10-24-17)21(32)28-8-12(7-23)9-28/h5-6,10,12H,2-4,8-9H2,1H3,(H,27,30)(H,24,25,26) QYGSXYGOQRMILS-UHFFFAOYSA-N 550661 1-({4-[(8′-Methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidin-6-yl}carbonyl)azetidine-3-carbonitrile::US11311520, Example 155 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.30 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550661 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550661&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259153 469794661 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162316 CN(C)[C@@H]1CCN(C1)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCC5)n4c3=O)ncnc2s1 InChI=1S/C24H27N7O3S/c1-13-9-16(22(33)31-18(13)20(32)28-24(31)6-4-7-24)27-19-15-10-17(35-21(15)26-12-25-19)23(34)30-8-5-14(11-30)29(2)3/h9-10,12,14H,4-8,11H2,1-3H3,(H,28,32)(H,25,26,27)/t14-/m1/s1 WLKMGMKDDNCPOW-CQSZACIVSA-N 550662 6′-[(6-{[(3R)-3-(Dimethylamino)pyrrolidin-1-yl]carbonyl}thieno[2,3-d]pyrimidin-4-yl)amino]-8′-methyl-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 156 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 4.30 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550662 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550662&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259078 469794662 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162317 CN(C)C1CCN(CC1)C(=O)c1cc2c(Nc3cc(C)c4C(=O)NC5(CCC5)n4c3=O)ncnc2s1 InChI=1S/C25H29N7O3S/c1-14-11-17(23(34)32-19(14)21(33)29-25(32)7-4-8-25)28-20-16-12-18(36-22(16)27-13-26-20)24(35)31-9-5-15(6-10-31)30(2)3/h11-13,15H,4-10H2,1-3H3,(H,29,33)(H,26,27,28) ZWOBDRPDWPSFFL-UHFFFAOYSA-N 550663 6′-[(6-{[4-(Dimethylamino)piperidin-1-yl]carbonyl}thieno[2,3-d]pyrimidin-4-yl)amino]-8′-methyl-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 157 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 7.90 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550663&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259232 469794663 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162318 Cc1cc(Nc2ncnc3sc(cc23)C(=O)N2C[C@@]3([W])C[C@@H]2CO3)c(=O)n2c1C(=O)NC21CCC1 InChI=1S/C23H21N6O4S.W/c1-11-5-15(21(31)29-17(11)19(30)27-23(29)3-2-4-23)26-18-14-7-16(34-20(14)25-10-24-18)22(32)28-8-13-6-12(28)9-33-13;/h5,7,10,12H,2-4,6,8-9H2,1H3,(H,27,30)(H,24,25,26);/t12-;/m1./s1 CZECBMBKFRUPPX-UTONKHPSSA-N 550664 8′-Methyl-6′-({6-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]hept-5-ylcarbonyl]thieno[2,3-d]pyrimidin-4-yl}amino)-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 158 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.00 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550664&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 156663048 469794664 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162319 Cc1cc(Nc2ncnc3[nH]cnc23)c(=O)n2c1C(=O)NC21CCC1 InChI=1S/C16H15N7O2/c1-8-5-9(21-13-10-12(18-6-17-10)19-7-20-13)15(25)23-11(8)14(24)22-16(23)3-2-4-16/h5-7H,2-4H2,1H3,(H,22,24)(H2,17,18,19,20,21) KIEWDLMTXZUIAD-UHFFFAOYSA-N 550665 8′-Methyl-6′-(9H-purin-6-ylamino)-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 159 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 2.10 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550665 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550665&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259190 469794665 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162320 Cc1cc(Nc2ncnc3[nH]ncc23)c(=O)n2c1C(=O)NC21CCC1 InChI=1S/C16H15N7O2/c1-8-5-10(20-12-9-6-19-22-13(9)18-7-17-12)15(25)23-11(8)14(24)21-16(23)3-2-4-16/h5-7H,2-4H2,1H3,(H,21,24)(H2,17,18,19,20,22) ZJJYGVRPEBDPOH-UHFFFAOYSA-N 550666 8′-Methyl-6′-(1H-pyrazolo[3,4-d]pyrimidin-4-ylamino)-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 160 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 2.90 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550666 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550666&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259026 469794666 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162321 Cc1cc(Nc2ncnc3sncc23)c(=O)n2c1C(=O)NC21CCC1 InChI=1S/C16H14N6O2S/c1-8-5-10(20-12-9-6-19-25-14(9)18-7-17-12)15(24)22-11(8)13(23)21-16(22)3-2-4-16/h5-7H,2-4H2,1H3,(H,21,23)(H,17,18,20) MBYZPVLVXLNQFP-UHFFFAOYSA-N 550667 8′-Methyl-6′-([1,3]thiazolo[5,4-d]pyrimidin-7-ylamino)-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 161 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 11.6 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550667 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550667&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 156186871 469794667 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162322 Cc1cc(Nc2ncnc3CN(Cc23)C(=O)OC(C)(C)C)c(=O)n2c1C(=O)NC21CCC1 InChI=1S/C22H26N6O4/c1-12-8-14(19(30)28-16(12)18(29)26-22(28)6-5-7-22)25-17-13-9-27(10-15(13)23-11-24-17)20(31)32-21(2,3)4/h8,11H,5-7,9-10H2,1-4H3,(H,26,29)(H,23,24,25) NXGZSNJYSNDHRV-UHFFFAOYSA-N 550668 US11311520, Example 162::tert-Butyl 4-[(8′-methyl-1′,5′-dioxo-1′,5′-dihydro-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxylate MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 21.7 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550668&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259159 469794668 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162323 Cc1cc(Nc2ncnc3CN(Cc23)C(=O)OC(C)(C)C)c(=O)n2c1C(=O)NC2(C)C InChI=1S/C21H26N6O4/c1-11-7-13(18(29)27-15(11)17(28)25-21(27,5)6)24-16-12-8-26(9-14(12)22-10-23-16)19(30)31-20(2,3)4/h7,10H,8-9H2,1-6H3,(H,25,28)(H,22,23,24) WPDCFQCBXSLQTF-UHFFFAOYSA-N 550669 US11311520, Example 163::tert-Butyl 4-[(3,3,8-trimethyl-1,5-dioxo-1,2,3,5-tetrahydroimidazo[1,5-a]pyridin-6-yl)amino]-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxylate MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 16.8 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550669 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550669&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402651 469794669 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162324 Cc1cc(Nc2ncnc3scnc23)c(=O)n2c1C(=O)NC2(C)C InChI=1S/C15H14N6O2S/c1-7-4-8(14(23)21-10(7)12(22)20-15(21,2)3)19-11-9-13(17-5-16-11)24-6-18-9/h4-6H,1-3H3,(H,20,22)(H,16,17,19) ODJPGEYHKGUTJB-UHFFFAOYSA-N 550670 3,3,8-Trimethyl-6-([1,3]thiazolo[5,4-d]pyrimidin-7-ylamino)-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione::US11311520, Example 164 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 383 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550670 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550670&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402614 469794670 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162325 Cc1cc(Nc2ncnc3CNCc23)c(=O)n2c1C(=O)NC2(C)C InChI=1S/C16H18N6O2/c1-8-4-10(15(24)22-12(8)14(23)21-16(22,2)3)20-13-9-5-17-6-11(9)18-7-19-13/h4,7,17H,5-6H2,1-3H3,(H,21,23)(H,18,19,20) KSJCIFVPUAACSB-UHFFFAOYSA-N 550671 6-(6,7-Dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-ylamino)-3,3,8-trimethyl-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione::US11311520, Example 165 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 168 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550671 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550671&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146257735 469794671 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162326 Cc1cc(Nc2ncnc3ccc(Cl)cc23)c(=O)n2c1C(=O)NC2(C)C InChI=1S/C18H16ClN5O2/c1-9-6-13(17(26)24-14(9)16(25)23-18(24,2)3)22-15-11-7-10(19)4-5-12(11)20-8-21-15/h4-8H,1-3H3,(H,23,25)(H,20,21,22) VAUHGLMTDFNIEL-UHFFFAOYSA-N 550672 6-[(6-Chloroquinazolin-4-yl)amino]-3,3,8-trimethyl-2,3-dihydroimidazo[1,5-a]pyridine-1,5-dione::US11311520, Example 166 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 45.9 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550672 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550672&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240056 469794672 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162327 Cc1cc(Nc2ncnc3ccc(Cl)cc23)c(=O)n2c1C(=O)NC21CCC1 InChI=1S/C19H16ClN5O2/c1-10-7-14(18(27)25-15(10)17(26)24-19(25)5-2-6-19)23-16-12-8-11(20)3-4-13(12)21-9-22-16/h3-4,7-9H,2,5-6H2,1H3,(H,24,26)(H,21,22,23) HNDPDILADXFBLM-UHFFFAOYSA-N 550673 6′-[(6-Chloroquinazolin-4-yl)amino]-8′-methyl-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 167 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.70 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550673&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259316 469794673 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162328 Cc1cc(Nc2ncnc3CNCc23)c(=O)n2c1C(=O)NC21CCC1 InChI=1S/C17H18N6O2/c1-9-5-11(21-14-10-6-18-7-12(10)19-8-20-14)16(25)23-13(9)15(24)22-17(23)3-2-4-17/h5,8,18H,2-4,6-7H2,1H3,(H,22,24)(H,19,20,21) UDTXLLOMQRATJB-UHFFFAOYSA-N 550674 6′-(6,7-Dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-ylamino)-8′-methyl-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 168 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 49.5 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550674 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550674&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259268 469794674 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162329 Cc1c(sc2ncnc(Nc3cc(C)c4C(=O)NC5(CCC5)n4c3=O)c12)C(O)=O InChI=1S/C19H17N5O4S/c1-8-6-10(17(26)24-12(8)15(25)23-19(24)4-3-5-19)22-14-11-9(2)13(18(27)28)29-16(11)21-7-20-14/h6-7H,3-5H2,1-2H3,(H,23,25)(H,27,28)(H,20,21,22) BTTOYQUGTFXDPF-UHFFFAOYSA-N 550675 5-Methyl-4-[(8′-methyl-1′,5′-dihydro-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridin]-6′-yl)amino]thieno[2,3-d]pyrimidine-6-carboxylic acid::US11311520, Example 169 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 15.7 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550675 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550675&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259252 469794675 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162330 Cc1cc(Nc2ncnc3cccc(C)c23)c(=O)n2c1C(=O)NC21CCC1 InChI=1S/C20H19N5O2/c1-11-5-3-6-13-15(11)17(22-10-21-13)23-14-9-12(2)16-18(26)24-20(7-4-8-20)25(16)19(14)27/h3,5-6,9-10H,4,7-8H2,1-2H3,(H,24,26)(H,21,22,23) PRNAIODUPJRPJX-UHFFFAOYSA-N 550676 8′-methyl-6′-[(5-methylquinazolin-4-yl)amino]-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 170 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.30 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550676 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550676&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259154 469794676 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162331 Cc1cc(Nc2ncnc3ccc(F)cc23)c(=O)n2c1C(=O)NC21CCC1 InChI=1S/C19H16FN5O2/c1-10-7-14(18(27)25-15(10)17(26)24-19(25)5-2-6-19)23-16-12-8-11(20)3-4-13(12)21-9-22-16/h3-4,7-9H,2,5-6H2,1H3,(H,24,26)(H,21,22,23) RJGWMZHKHBMJEL-UHFFFAOYSA-N 550677 6′-[(6-fluoroquinazolin-4-yl)amino]-8′-methyl-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 171 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 6.00 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550677&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259266 469794677 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162332 Cc1cc(Nc2ncnc3ccccc23)c(=O)n2c1C(=O)NC21CCC1 InChI=1S/C19H17N5O2/c1-11-9-14(22-16-12-5-2-3-6-13(12)20-10-21-16)18(26)24-15(11)17(25)23-19(24)7-4-8-19/h2-3,5-6,9-10H,4,7-8H2,1H3,(H,23,25)(H,20,21,22) DXXYFWMGJCONPS-UHFFFAOYSA-N 550678 8′-methyl-6′-[(quinazolin-4-yl)amino]-2′H-spiro[cyclobutane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 172 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 12.1 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550678&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402610 469794678 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162333 Cc1cc(Nc2ncnc3scnc23)c(=O)n2c1C(=O)NC21CSC1 InChI=1S/C15H12N6O2S2/c1-7-2-8(19-11-9-13(17-5-16-11)25-6-18-9)14(23)21-10(7)12(22)20-15(21)3-24-4-15/h2,5-6H,3-4H2,1H3,(H,20,22)(H,16,17,19) ROGJXADPVZKWIN-UHFFFAOYSA-N 550679 8-methyl-6-[([1,3]thiazolo[5,4-d]pyrimidin-7-yl)amino]-2H-spiro[imidazo[1,5-a]pyridine-3,3′-thietane]-1,5-dione::US11311520, Example 173 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.80 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550679&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259210 469794679 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162334 Cc1cc(Nc2ncnc3cccc(C)c23)c(=O)n2c1C(=O)NC21CSC1 InChI=1S/C19H17N5O2S/c1-10-4-3-5-12-14(10)16(21-9-20-12)22-13-6-11(2)15-17(25)23-19(7-27-8-19)24(15)18(13)26/h3-6,9H,7-8H2,1-2H3,(H,23,25)(H,20,21,22) MGOGHLRIRIJFBJ-UHFFFAOYSA-N 550680 8-methyl-6-[(5-methylquinazolin-4-yl)amino]-2H-spiro[imidazo[1,5-a]pyridine-3,3′-thietane]-1,5-dione::US11311520, Example 174 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 12.8 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550680 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550680&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259228 469794680 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162335 Cc1cc(Nc2ncnc3ccc(Cl)cc23)c(=O)n2c1C(=O)NC21CSC1 InChI=1S/C18H14ClN5O2S/c1-9-4-13(17(26)24-14(9)16(25)23-18(24)6-27-7-18)22-15-11-5-10(19)2-3-12(11)20-8-21-15/h2-5,8H,6-7H2,1H3,(H,23,25)(H,20,21,22) MZRAKJFBPZFIMC-UHFFFAOYSA-N 550681 6-[(6-chloroquinazolin-4-yl)amino]-8-methyl-2H-spiro[imidazo[1,5-a]pyridine-3,3′-thietane]-1,5-dione::US11311520, Example 175 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 14.4 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550681 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550681&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240103 469794681 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162336 Cc1cc(Nc2ncnc3ccc(F)cc23)c(=O)n2c1C(=O)NC21CSC1 InChI=1S/C18H14FN5O2S/c1-9-4-13(17(26)24-14(9)16(25)23-18(24)6-27-7-18)22-15-11-5-10(19)2-3-12(11)20-8-21-15/h2-5,8H,6-7H2,1H3,(H,23,25)(H,20,21,22) PWJXMLVUFHVYNJ-UHFFFAOYSA-N 550682 6-[(6-fluoroquinazolin-4-yl)amino]-8-methyl-2H-spiro[imidazo[1,5-a]pyridine-3,3′-thietane]-1,5-dione::US11311520, Example 176 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 19.0 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550682 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550682&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240074 469794682 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162337 Cc1cc(Nc2ncnc3sccc23)c(=O)n2c1C(=O)NC21CSC1 InChI=1S/C16H13N5O2S2/c1-8-4-10(19-12-9-2-3-25-14(9)18-7-17-12)15(23)21-11(8)13(22)20-16(21)5-24-6-16/h2-4,7H,5-6H2,1H3,(H,20,22)(H,17,18,19) LBIZICUDLJJJIP-UHFFFAOYSA-N 550683 8-methyl-6-[(thieno[2,3-d]pyrimidin-4-yl)amino]-2H-spiro[imidazo[1,5-a]pyridine-3,3′-thietane]-1,5-dione::US11311520, Example 177 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 4.30 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550683&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240050 469794683 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162338 Cc1cc(Nc2ncnc3[nH]ccc23)c(=O)n2c1C(=O)NC21CSC1 InChI=1S/C16H14N6O2S/c1-8-4-10(20-13-9-2-3-17-12(9)18-7-19-13)15(24)22-11(8)14(23)21-16(22)5-25-6-16/h2-4,7H,5-6H2,1H3,(H,21,23)(H2,17,18,19,20) QEYRMIPSUBGLHN-UHFFFAOYSA-N 550684 8-methyl-6-[(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-2H-spiro[imidazo[1,5-a]pyridine-3,3′-thietane]-1,5-dione::US11311520, Example 178 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 1.10 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550684 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550684&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135242336 469794684 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162339 Cc1cc(Nc2ncnc3cccc(C)c23)c(=O)n2c1C(=O)NC21CS(=O)(=O)C1 InChI=1S/C19H17N5O4S/c1-10-4-3-5-12-14(10)16(21-9-20-12)22-13-6-11(2)15-17(25)23-19(24(15)18(13)26)7-29(27,28)8-19/h3-6,9H,7-8H2,1-2H3,(H,23,25)(H,20,21,22) LKVZABYJJXYXHS-UHFFFAOYSA-N 550685 8-methyl-6-[(5-methylquinazolin-4-yl)amino]-2H-spiro[imidazo[1,5-a]pyridine-3,3′-thietane]-1,5-dione 1′,1′-dioxide::US11311520, Example 179 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 124 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550685 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550685&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146257739 469794685 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162340 Cc1cc(Nc2ncnc3ccc(Cl)cc23)c(=O)n2c1C(=O)NC21CS(=O)(=O)C1 InChI=1S/C18H14ClN5O4S/c1-9-4-13(22-15-11-5-10(19)2-3-12(11)20-8-21-15)17(26)24-14(9)16(25)23-18(24)6-29(27,28)7-18/h2-5,8H,6-7H2,1H3,(H,23,25)(H,20,21,22) UBJITKREDHXBND-UHFFFAOYSA-N 550686 6-[(6-chloroquinazolin-4-yl)amino]-8-methyl-2H-spiro[imidazo[1,5-a]pyridine-3,3′-thietane]-1,5-dione 1′,1′-dioxide::US11311520, Example 180 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 104 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550686&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146257736 469794686 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162341 Cc1cc(Nc2ncnc3cc(Cl)ccc23)c(=O)n2c1C(=O)NC21CS(=O)(=O)C1 InChI=1S/C18H14ClN5O4S/c1-9-4-13(22-15-11-3-2-10(19)5-12(11)20-8-21-15)17(26)24-14(9)16(25)23-18(24)6-29(27,28)7-18/h2-5,8H,6-7H2,1H3,(H,23,25)(H,20,21,22) IEALJAYCOMTOIQ-UHFFFAOYSA-N 550687 6-[(7-chloroquinazolin-4-yl)amino]-8-methyl-2H-spiro[imidazo[1,5-a]pyridine-3,3′-thietane]-1,5-dione 1′,1′-dioxide::US11311520, Example 181 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 104 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550687 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550687&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402611 469794687 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162342 Cc1cc(Nc2ncnc3ccccc23)c(=O)n2c1C(=O)NC21CS(=O)(=O)C1 InChI=1S/C18H15N5O4S/c1-10-6-13(21-15-11-4-2-3-5-12(11)19-9-20-15)17(25)23-14(10)16(24)22-18(23)7-28(26,27)8-18/h2-6,9H,7-8H2,1H3,(H,22,24)(H,19,20,21) LYAWOZNXFDQJCR-UHFFFAOYSA-N 550688 8-methyl-6-(quinazolin-4-ylamino)-2H-spiro[imidazo[1,5-a]pyridine-3,3′-thietane]-1,5-dione 1′,1′-dioxide::US11311520, Example 182 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 261 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550688 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550688&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146257757 469794688 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162343 Cc1cc(Nc2ncnc3cccc(C)c23)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C21H21N5O2/c1-12-6-5-7-14-16(12)18(23-11-22-14)24-15-10-13(2)17-19(27)25-21(8-3-4-9-21)26(17)20(15)28/h5-7,10-11H,3-4,8-9H2,1-2H3,(H,25,27)(H,22,23,24) LJPVPWNBJLIWBB-UHFFFAOYSA-N 550689 8′-methyl-6′-[(5-methylquinazolin-4-yl)amino]-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 183 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 13.0 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550689 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550689&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259028 469794689 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162344 Cc1cc(Nc2ncnc3ccc(cc23)C(F)(F)F)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C21H18F3N5O2/c1-11-8-15(19(31)29-16(11)18(30)28-20(29)6-2-3-7-20)27-17-13-9-12(21(22,23)24)4-5-14(13)25-10-26-17/h4-5,8-10H,2-3,6-7H2,1H3,(H,28,30)(H,25,26,27) ZWDQJNFJOOPAPY-UHFFFAOYSA-N 550690 8′-methyl-6′-{[6-(trifluoromethyl)quinazolin-4-yl]amino}-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 184 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 34.0 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550690&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402558 469794690 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162345 Cc1cc(Nc2ncnc3ccc(F)cc23)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C20H18FN5O2/c1-11-8-15(24-17-13-9-12(21)4-5-14(13)22-10-23-17)19(28)26-16(11)18(27)25-20(26)6-2-3-7-20/h4-5,8-10H,2-3,6-7H2,1H3,(H,25,27)(H,22,23,24) FHOIBRMONMHQLO-UHFFFAOYSA-N 550691 6′-[(6-fluoroquinazolin-4-yl)amino]-8′-methyl-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 185 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 7.90 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550691 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550691&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259151 469794691 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162346 Cc1cc(Nc2ncnc3cc(Cl)ccc23)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C20H18ClN5O2/c1-11-8-15(24-17-13-5-4-12(21)9-14(13)22-10-23-17)19(28)26-16(11)18(27)25-20(26)6-2-3-7-20/h4-5,8-10H,2-3,6-7H2,1H3,(H,25,27)(H,22,23,24) VHBYNMULWMWCTB-UHFFFAOYSA-N 550692 6′-[(7-chloroquinazolin-4-yl)amino]-8′-methyl-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 186 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.50 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550692&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259281 469794692 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162347 Cc1cc(Nc2ncnc3ccccc23)c(=O)n2c1C(=O)NC21CCCC1 InChI=1S/C20H19N5O2/c1-12-10-15(23-17-13-6-2-3-7-14(13)21-11-22-17)19(27)25-16(12)18(26)24-20(25)8-4-5-9-20/h2-3,6-7,10-11H,4-5,8-9H2,1H3,(H,24,26)(H,21,22,23) HHRDOEWVDDFLQI-UHFFFAOYSA-N 550693 8′-methyl-6′-[(quinazolin-4-yl)amino]-2′H-spiro[cyclopentane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 187 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 7.30 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550693&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 142402649 469794693 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162348 Cc1cc(Nc2ncnc3cccc(C)c23)c(=O)n2c1C(=O)N[C@]21CC[C@](O)(CC1)C(F)(F)F InChI=1S/C23H22F3N5O3/c1-12-4-3-5-14-16(12)18(28-11-27-14)29-15-10-13(2)17-19(32)30-22(31(17)20(15)33)8-6-21(34,7-9-22)23(24,25)26/h3-5,10-11,34H,6-9H2,1-2H3,(H,30,32)(H,27,28,29)/t21-,22+ HNPJVGUPEXYAMS-SZPZYZBQSA-N 550694 (cis)-4-hydroxy-8′-methyl-6′-[(5-methylquinazolin-4-yl)amino]-4-(trifluoromethyl)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 188 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 47.0 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550694&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259260 469794694 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162349 Cc1cc(Nc2ncnc3ccc(F)cc23)c(=O)n2c1C(=O)N[C@]21CC[C@](O)(CC1)C(F)(F)F InChI=1S/C22H19F4N5O3/c1-11-8-15(29-17-13-9-12(23)2-3-14(13)27-10-28-17)19(33)31-16(11)18(32)30-21(31)6-4-20(34,5-7-21)22(24,25)26/h2-3,8-10,34H,4-7H2,1H3,(H,30,32)(H,27,28,29)/t20-,21+ MDFBNOGCXHYNGU-OYRHEFFESA-N 550695 (cis)-6′-[(6-fluoroquinazolin-4-yl)amino]-4-hydroxy-8′-methyl-4-(trifluoromethyl)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 189 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 274 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550695&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259276 469794695 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162350 Cc1cc(Nc2ncnc(N)n2)c(=O)n2c1C(=O)N[C@]21CC[C@](O)(CC1)C(F)(F)F InChI=1S/C17H18F3N7O3/c1-8-6-9(24-14-23-7-22-13(21)25-14)12(29)27-10(8)11(28)26-16(27)4-2-15(30,3-5-16)17(18,19)20/h6-7,30H,2-5H2,1H3,(H,26,28)(H3,21,22,23,24,25)/t15-,16+ HRTPGAXURJTPGQ-IYBDPMFKSA-N 550696 (cis)-6′-[(4-amino-1,3,5-triazin-2-yl)amino]-4-hydroxy-8′-methyl-4-(trifluoromethyl)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 190 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 31.4 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550696&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259155 469794696 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162351 Cc1cc(Nc2ncnc3cccc(C)c23)c(=O)n2c1C(=O)N[C@]21CC[C@](O)(CC1)C(F)(F)C(F)(F)F InChI=1S/C24H22F5N5O3/c1-12-4-3-5-14-16(12)18(31-11-30-14)32-15-10-13(2)17-19(35)33-22(34(17)20(15)36)8-6-21(37,7-9-22)23(25,26)24(27,28)29/h3-5,10-11,37H,6-9H2,1-2H3,(H,33,35)(H,30,31,32)/t21-,22+ OFJHUIDLHBQHGE-SZPZYZBQSA-N 550697 (cis)-4-hydroxy-8′-methyl-6′-[(5-methylquinazolin-4-yl)amino]-4-(pentafluoroethyl)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 191 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 67.8 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550697&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259168 469794697 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162352 Cc1cc(Nc2ncnc3ccc(F)cc23)c(=O)n2c1C(=O)N[C@]21CC[C@](O)(CC1)C(F)(F)C(F)(F)F InChI=1S/C23H19F6N5O3/c1-11-8-15(32-17-13-9-12(24)2-3-14(13)30-10-31-17)19(36)34-16(11)18(35)33-21(34)6-4-20(37,5-7-21)22(25,26)23(27,28)29/h2-3,8-10,37H,4-7H2,1H3,(H,33,35)(H,30,31,32)/t20-,21+ JJDVRGNPQPQMFE-OYRHEFFESA-N 550698 (cis)-6′-[(6-fluoroquinazolin-4-yl)amino]-4-hydroxy-8′-methyl-4-(pentafluoroethyl)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 192 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 281 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550698&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259231 469794698 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162353 Cc1cc(Nc2ncnc3sccc23)c(=O)n2c1C(=O)N[C@]21CC[C@](O)(CC1)C(F)(F)C(F)(F)F InChI=1S/C21H18F5N5O3S/c1-10-8-12(29-14-11-2-7-35-16(11)28-9-27-14)17(33)31-13(10)15(32)30-19(31)5-3-18(34,4-6-19)20(22,23)21(24,25)26/h2,7-9,34H,3-6H2,1H3,(H,30,32)(H,27,28,29)/t18-,19+ DOZONPAULFOQBP-KDURUIRLSA-N 550699 (cis)-4-hydroxy-8′-methyl-4-(pentafluoroethyl)-6′-[(thieno[2,3-d]pyrimidin-4-yl)amino]-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 193 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 29.8 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550699&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259277 469794699 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162354 Cc1cc(Nc2ncnc3[nH]ccc23)c(=O)n2c1C(=O)N[C@]21CC[C@](O)(CC1)C(F)(F)C(F)(F)F 550700 (cis)-4-hydroxy-8′-methyl-4-(pentafluoroethyl)-6′-[(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 194 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 12.2 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550700&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259219 469794700 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162355 Cc1cc(Nc2ncnc3ccc(Cl)cc23)c(=O)n2c1C(=O)N[C@]21CC[C@](O)(CC1)C(F)(F)C(F)(F)F InChI=1S/C23H19ClF5N5O3/c1-11-8-15(32-17-13-9-12(24)2-3-14(13)30-10-31-17)19(36)34-16(11)18(35)33-21(34)6-4-20(37,5-7-21)22(25,26)23(27,28)29/h2-3,8-10,37H,4-7H2,1H3,(H,33,35)(H,30,31,32)/t20-,21+ JEDTXNJLIVGHBC-OYRHEFFESA-N 550701 (cis)-6′-[(6-chloroquinazolin-4-yl)amino]-4-hydroxy-8′-methyl-4-(pentafluoroethyl)-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione::US11311520, Example 195 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 342 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550701&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146257740 469794701 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162356 Cc1cc(Nc2ncnc3[nH]ccc23)c(=O)n2c1C(=O)NC21CCSCC1 InChI=1S/C18H18N6O2S/c1-10-8-12(22-15-11-2-5-19-14(11)20-9-21-15)17(26)24-13(10)16(25)23-18(24)3-6-27-7-4-18/h2,5,8-9H,3-4,6-7H2,1H3,(H,23,25)(H2,19,20,21,22) QYQZEPULBTZQQB-UHFFFAOYSA-N 550702 8-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-2′,3′,5′,6′-tetrahydro-2H-spiro[imidazo[1,5-a]pyridine-3,4′-thiopyran]-1,5-dione::US11311520, Example 196 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 0.500 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550702&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259234 469794702 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162357 Cc1cc(Nc2ncnc3ccc(Cl)cc23)c(=O)n2c1C(=O)NC21CCSCC1 InChI=1S/C20H18ClN5O2S/c1-11-8-15(24-17-13-9-12(21)2-3-14(13)22-10-23-17)19(28)26-16(11)18(27)25-20(26)4-6-29-7-5-20/h2-3,8-10H,4-7H2,1H3,(H,25,27)(H,22,23,24) YQIPNNPXXOAMND-UHFFFAOYSA-N 550703 6-[(6-chloroquinazolin-4-yl)amino]-8-methyl-2′,3′,5′,6′-tetrahydro-2H-spiro[imidazo[1,5-a]pyridine-3,4′-thiopyran]-1,5-dione::US11311520, Example 197 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 14.9 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550703&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135240066 469794703 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162358 Cc1cc(Nc2ncnc3[nH]ccc23)c(=O)n2c1C(=O)NC21CCS(=O)(=O)CC1 InChI=1S/C18H18N6O4S/c1-10-8-12(22-15-11-2-5-19-14(11)20-9-21-15)17(26)24-13(10)16(25)23-18(24)3-6-29(27,28)7-4-18/h2,5,8-9H,3-4,6-7H2,1H3,(H,23,25)(H2,19,20,21,22) OASWJZXRXNQVMI-UHFFFAOYSA-N 550704 8-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-2′,3′,5′,6′-tetrahydro-2H-spiro[imidazo[1,5-a]pyridine-3,4′-thiopyran]-1,5-dione 1′,1′-dioxide::US11311520, Example 198 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 1.10 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550704&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259201 469794704 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1162359 Cc1cc(Nc2ncnc3ccc(Cl)cc23)c(=O)n2c1C(=O)NC21CCS(=O)(=O)CC1 InChI=1S/C20H18ClN5O4S/c1-11-8-15(24-17-13-9-12(21)2-3-14(13)22-10-23-17)19(28)26-16(11)18(27)25-20(26)4-6-31(29,30)7-5-20/h2-3,8-10H,4-7H2,1H3,(H,25,27)(H,22,23,24) GPBQVAIDIOQKSF-UHFFFAOYSA-N 550705 6-[(6-chloroquinazolin-4-yl)amino]-8-methyl-2′,3′,5′,6′-tetrahydro-2H-spiro[imidazo[1,5-a]pyridine-3,4′-thiopyran]-1,5-dione 1′,1′-dioxide::US11311520, Example 199 MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 56.3 US Patent 10.7270/Q2VT1W9T aid1806470 US11311520 Klar, U; Bohlmann, R; Schacke, H; Sulzle, D; Menz, S; Panknin, O 4/26/2022 8/6/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=550705 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=550705&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 135259197 469794705 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6